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SUMMARY
The GnRH receptor is a G-protein-coupled receptor in pituitary gonadotrope
cells. Binding of its ligand, GnRH, results in synthesis and release of
gonadotropin hormones luteinizing hormone (LH) and follicle stimulating
hormone (FSH). Steroidogenic factor 1 (SF-1), a transcription factor, binds
to specific sites in the promoter region of gonadotropin genes, and thus
regulates transcription of these genes. The promoter region of the GnRH-
receptor gene contains two SF-1-like binding sites, one at -14 to -8 (site 1)
and another at -247 to -239 (site 2), relative to the methionine start codon.
The role played by these two SF-1-like sites in basal transcription of the
mouse GnRH receptor (mGnRH-R) gene in a pituitary precursor
gonadotrope cell line, aT3 cells, was the first area of investigation during this
study. Luciferase reporter constructs containing 580 bp of mGnRH-R gene
promoter were prepared, where SF-1-like sites were either wildtype or
mutated. Four such constructs were made, i.e. wildtype (LG), site 1 mutant
(LGM1), site 2 mutant (LGM2) and mutated site 1 plus site 2 (LGM1/2).
These constructs were transfected into aT3 cells to determine the effect of
mutations of sites 1 and/or 2 on the basal expression of the mGnRH-R gene.
Mutation of either site 1 or site 2 had no effect on basal expression of the
mGnRH-R gene. It was found that only upon simultaneous mutation of both
sites 1 and 2, a 50% reduction in basal transcription took place. The
implications of this is that SF-1 protein seems to only require one intact
DNA-binding site, to mediate basal transcription of the mGnRH-R gene,
suggesting that these two sites lie in close proximity during basal
transcription. The effect of the protein kinase A (PKA) pathway on the
endogenou~ fTlGnRH-R gene was also investigated by incubating non-
, \
transfected aT3 cells with the PKA activators, forskolin and 8-Br-cAMP.
Similar incubations were also performed on the wild type and mutated site 1
constructs transfected into pituitary gonadotrope aT3 cells. It was found that
forskolin and 8-Br-cAMP were able to increase endogenous mGnRH-R
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mRNA levels in a concentration-dependent fashion, showing that
endogenous GnRH receptor gene expression is stimulated via a protein
kinase A pathway. Similar results were obtained with the wildtype promoter
construct, showing that the protein kinase A pathway stimulates transcription
of the promoter. This effect was only seen with wild type and not with the
mutated site 1. These results are consistent with a role for a SF-1-like
transcription factor in mediating the protein kinase A effect via binding to the
site 1 at position -14 in the GnRH receptor gene. A separate investigation
was performed to determine whether 25-hydroxycholesterol (25-0HC) is a
ligand for SF-1, by incubating aT3 cells transfected with the various
constructs with 25-0HC. Results show a dose-dependant response, with an
increase in gene expression at 1 J.lM and a decrease at higher
concentrations, for both mutant and wild type constructs. This suggests that,
if SF-1 is indeed the protein binding to sites 1 and 2, then 25-0HC is not a
ligand for SF-1 protein in aT3 cells and that the effect of 25-0HC on the
mGnRH-R gene is not mediated via site 1. The results indicate that these
decreases of expression at the higher concentrations may be due to
cytotoxic effects. Towards the end of the study the laboratory obtained a
luminoskan instrument with automatic dispensing features. Optimisation
studies on the luciferase and p-Gal assays were performed on the
luminoskan in a bid to decrease experimental error. It was found that
automation of these assays resulted in a decrease in experimental error,
showing that future researchers could benefit substantially from these
optimisation studies.
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OPSOMMING
Die GnRH reseptor is 'n G proteïen-gekoppelde reseptor in pituitêre
gonadotroopselle. Binding van die ligand, GnRH, lei tot die sintese en
vrystelling van die gonadotropien hormone, luteïniserende hormoon (LH) en
follikel stimulerende hormoon (FSH). Steroidogeniese taktor-t (SF-1) is 'n
transkripsie faktor wat aan spesifieke areas in die promotergebied van die
gonadotropien hormone bind, en dus transkripsie van hierdie gene reguleer.
Die promotergebied van die GnRH reseptor geen bevat twee SF-1 bindings
areas, een by -14 to -8 (area 1) asook by -247 to -239 (area 2), relatief to die
metionien beginkodon. Die rol wat hierdie twee SF-1 areas speel in basale
transkripsie van die muis GnRH reseptor (mGnRH-R) geen in 'n pituïtêre
voorloper gonadotroop sellyn. aT3 selle, was die eerste gebied van
ondersoek gedurende hierdie studie. Plasmiede bestaande uit die 580
basispaar mGnRH-R promoter verbind aan 'n lusiferase geen is vervaardig,
waar SF-1-soortige areas enersyds onveranderd gelaat is, of gemuteer is.
Vier sulke plasmiede is vervaardig, nl. onveranderd (LG), area 1 mutant
(LGM1), area 2 mutant (LGM2) en gemuteerde area 1 plus area 2 (LGM1/2).
Hierdie plasmiede is gebruik om aT3 selle te transfekteer om die effek van
mutasies van areas 1 en/of 2 op die basale ekspressie van die mGnRH-R
geen te ondersoek. Daar is gevind dat mutasies van areas 1 of 2 geen effek
op basale ekspressie op die bogenoemde geen gehad het nie. Slegs tydens
gelyktydige mutasie van areas 1 en 2 het 'n 50% vermindering in basale
transkripsie plaasgevind. Die implikasies hiervan is dat die SF-1 proteïen
blykbaar slegs een volledige DNA-bindingsarea benodig om basale
transkripsie van die mGnRH-R geen te reguleer. Dit wil dus voorkom of
hierdie twee areas baie na aan mekaar geposisioneer is tydens basale
transkripsie. Die effek van die proteïen kinase A (PKA) roete op die natuurlike
mGnRH-R geen is ook ondersoek tydens inkubasie van nie-getransfekteerde
aT3 selle met die PKA akiveerders, forskolin en 8-Br-cAMP. Soortgelyke
inkubasie is ook gedoen op die onveranderde en gemuteerde area 1
plasmiede wat in aT3 selle getransfekteer is. Daar is gevind dat forskolin en
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a-Sr-cAMP daarin geslaag het om die natuurlike mGnRH-R geen mRNA
vlakke op 'n konsentrasie-afhanklike wyse te vermeerder. Hierdie resultaat
dui daarop aan dat die natuurlike mGnRH-R geen se ekspressie gestimuleer
kan word via 'n proteïen kinase A roete. Soortgelyke resultate is verkry met
die onveranderde promoter plasmied en dit wys ook daarop dat proteïen
kinase A transkripsie deur die promoter kan stimuleer. Hierdie effek was
slegs aanwesig met die onveranderde en nie met die gemuteerde area 1
plasmied nie. Die resultate stem ooreen met 'n rol vir SF-1 transkripsie faktor
in die regulering van proteren kinase A effek deur middel van binding aan die
area 1 by posisie -14 in die GnRH-R geen. 'n Afsonderlike ondersoek is
gedoen om vas te stelof 25-hidroksiecholesterol (25-0HC) 'n ligand vir SF-1
is deur getransfekteerde aT3 selle met 25-0HC te inkubeer. Resultate toon 'n
dosis-afhanklike respons met 'n verhoging in geen ekspressie by 1 11Men 'n
verlaging met hoër konsentrasies vir beide onveranderde en gemuteerde
plasmiede. Dit impliseer dat, indien SF-1 wel die faktor is wat aan areas 1 en
2 bind, 25-0HC nie die ligand vir SF-1 proteren in aT3 selle is nie en dat die
effek van 25-0HC op die mGnRH-R geen nie gereguleer word via area 1 nie.
Die verlaging in ekspressie gevind by die hoër konsentrasies is dalk die
gevolg van sitotoksiese effekte. Teen die einde van die studie het die
laboratorium luminoskan toerusting met outomatiese pipettering verkry.
Optimiseringstudies van die lusifirase en f3-Galtoetse is met die luminoskan
gedoen in 'n poging om eksperimentele foute te minimaliseer. Daar is gevind
dat outomatisering van hierdie toetse wel gelei het tot 'n verlaging in
eksperimentele foute. Toekomstige navorsers kan dus grootliks voordeel trek
uit hierdie optimiseringstudies.
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AIM OF THIS STUDY
The aim of this study was as follows: to study the role that steroidogenic
factor-1 (SF-1) plays in the transcriptional regulation of the mouse
gonadotropin-releasing hormone receptor (mGnRH-R) gene. This was done
by using a part of the GnRH receptor gene promoter region that contained
two SF-1-like sites (sites 1 and 2), linked to a luciferase reporter construct.
Transfection experiments were carried out on a mouse pituitary clonal cell
line, i.e. aT3 cells. Some of the important questions that were investigated in
this study are outlined below:
1. Does the SF-1-like site 1, in the mGnRH-R promoter region, playa role
in basal transcription of this gene?
2. Does the SF-1-like site 2, in the mGnRH-R promoter region, playa role
in basal transcription of this gene?
3. Does the simultaneous mutation of both these SF-1-like sites affect the
basal transcription of.the mGnRH-R gene?
4. Do activators of the protein kinase A (PKA) pathway have an effect on
the expression levels of endogenous mGnRH-R mRNA in aT3 clonal
cells?
5. Is transcription of the mGnRH-R gene regulated by the actions of the
PKA pathway?
6. If the answer to question 5 is yes, then do the SF-1-like sites 1 and 2,
mediate this response?
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7. Does 25-hydroxycholesterol play a role in transcriptional regulation of
the mGnRH-R gene, and if so, is this effect mediated by the SF-1-like
site 1?
Additionally the optimisation of some of the experimental procedures, i.e. the
luciferase and p-galactosidase assays will also be performed, in order to
minimise experimental error in future experiments of this nature.
Previous work done in our laboratory on the mGnRH-R gene, by Janet
Hapgood and Carmen Pheiffer involved the identification of the transcriptional
start site, mutagenesis of SF-1-like site 1 and preliminary transfection
studies. Work being done in our laboratory, by Hanel Sadie, (in parallel to the
present thesis) focuses mainly on identifying the proteins in a T3 cells that
bind to these SF-1-like sites in the mGnRH-R, using the technique of
electrophoretic mobility shift assays (EMSA) or gelshifts. It is hoped, to one
day, have a, complete picture of mGnRH-R gene regulation and the role that
SF-1 pretein plays in that regulation in aT3 cells.
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1CHAPTER 1
INTRODUCTION
1. The role of GnRH receptor in the Hypothalamic-Pituitary-Gonadal
(HPG) axis
A.) Characterisation of the GnRH receptor and its second messenger
pathways
Gonadotropin-releasing hormone (GnRH), a decapeptide (pyro-Glu-His-Tyr-
Ser-Tyr-Gly-Leu-Arq-Pro-Gly-Nl-l-) [1] is synthesised by the hypothalamic
neurons and released in a pulsatile fashion. In the pituitary it binds to its
specific receptor (GnRH receptor, see figure 1.1 for a diagrammatic
representation of the GnRH receptor), a member of the G-protein coupled
receptor (GPCR) family, and stimulates the release of the gonadotropins
luteinizing hormone (LH) and follicle stimulating hormone (FSH) [2] (see
figure 1.4). GnRH receptors have also been found in the hypothalamic
neurons that release GnRH-[3] as well as other regions of the brain including
the olfactory system, lateral septum, parasubiculum and the hippocampus [4]
where they are thought to act as neurotransmitter receptors linking the
endocrine effects of GnRH to reproductive behaviour. The GnRH receptor
has recently been identified in the gonadal tissues of rats [5] and it has been
postulated that this receptor allows GnRH to have a direct influence on the
gonads.
The pituitary is made up of five different cell types i.e. gonadotropes,
thyrotropes, lactotropes, somatolactotropes and corticotropes. Of these only
gonadotropes express the GnRH receptor on their cell surfaces [6, 7]. The
GnRH receptor is a 327 amino acid peptide and forms the distinctive seven
transmembrane domains that are associated with the GPCR family [2].
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2Figure 1.1: The proposed structural configuration of the GnRH receptor in the membrane,
showing the seven transmembrane domains as well as the absence of an intracellular C-
terminal tail. Figure taken from Hom F., Weare J., Beukers M.W., Horsch S., Bairoch A.,
Chen W., Edvardsen 0., Campagne F., and Vriend G. (1998) GPCRDB: an information
system for G protein-coupled receptors. Nucleic Acids Res. 26(1): 277-281 and the G
Protein Coupled Receptor DataBase (GPCRDB) at http://www.cmbi.kun.nll7tm/.
Unlike other members of this family the GnRH receptor lacks an intracellular
C-terminal tail [8, 9] (see figure 1.1). Until recently it was thought that the
GnRH receptor, like other members of the GPCR family, functions only as a
monomeric unit, but recent evidence suggests that the induction of receptor
aggregation is sufficient for activation. HOI/lever, whether this phenomenon of
selt-aqqreqation occurs under physiological conditions still remains to be
seen [10]. It has also long been the theory that the GnRH receptor was only
associated with the Gq/11protein, but a recent study in rat gonadotropes by
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3Stanislaus, D. et al. (1998) [11] showed that the GnRH receptor could
associate with Gia, Gsaand Gql11a proteins in a single cell, a fact that will be
discussed in more detail later on.
After binding of GnRH to its receptor in pituitary gonadotropes, various
second messenger pathways are activated to regulate the transcription of the
gonadotropin genes as well as its own receptor gene. The most well known
second messenger pathway for the GnRH receptor takes place as follows:
GnRH binds to its receptor which is coupled to the Gq/11a protein. The a
subunit of the Gq/11 protein in turn activates the membrane associated
phospholipase C, which produces the second messengers inositol(1,4,5)-
triphosphate (IP3) and diacylglycerol (DAG). IP3 leads to the mobilisation and
influx of Ca2+ ions and together with DAG can activate and translocate protein
kinase C (PKC) [2, 12]. Recently the picture has been elucidated more clearly
and there seems to be a complex series of events that coincide with the
above including the activation of phospholipases PLD and PLA2, release of
arachidonic acid and formation of bioactive lipoxygenase products that all
playa role in gonadotropin and GnRH receptor gene regulation [13, 14]. An
example of the activation of~thePKC pathway by the growth factor receptor is
shown in figure 1.2. Although it differs slightly from GnRH receptor activation
of the PKC pathway, the end result is the same in both cases.
The above however is just the tip of a very complex iceberg. The next steps
of the signal transduction pathway involve a series of phosphorylation steps.
The Ca2+ ion influx into the cell can also activate calmodulin kinase II, which
further phosphorylates RAS-GTPase-activating protein (RAS-GAP) [15].
RAS-GAP will in turn lead to the activation of a pathway of serine/threonine
protein kinases called the mitogen-activated protein kinase or MAPK
pathway. A spate of new evidence [13,15,16,17,18 and 19] has shown that
the MAPK pathway plays a role in the second messenger pathway of the
GnRH receptor. RAS-GAP phosphorylates MAPK kinase kinase (MAPKKK or
Raf), which in turn phosphorylates MAPK kinase (MAPKK or MEK), which
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4phosphorylates MAP or ERK (extracellular siqnal-requtated kinase), ERK is
the kinase which can then finally phosphorylate a specific transcription factor,
so that transcription of a target gene can take place [14, 20].
Grovth factor Cf-iM!.IC'ed
receptor A,' '.J'1JfmennflO/l
'\_CD .,...
Activated tgrosi ne
kinase - reee ptor
Tljrosine J:iMSe 8Ctil''Btio/l
J. (8utD)pMspftorljlBtio/t ______ -----
_.,.~
,.~ ...
&ot;nitio/t
BM 8indi/ll) Activated
Phospholipase C,l
SH2/)QffI8in
pMspftor IjMion
PlPz
PMspMtidljl- inositol
hlj(irolljSis
IAadive target
(Phospholipase C,l)
Figure 1,2: A diagrammatic scheme of the activation of the PKC pathway by the growth
factor receptor. The abbreviations used are as follows: GF = Growth Factor, IP3 = inositol
1,4,5-triphosphate, DG = diacylglycerol, cAMP = cyclic 3',5'-adenosine monoonesonate. Ca2+
= calcium ion, P = phosphate group, PI = phosphotnositol, PIP2 = inositol 4,S-bisphosphate.
Figure taken from http:\\www.bgu.ac.ill-aflaloclbiocal and is copyrighted to Claude Aftalo.
The other well known signal transduction pathway involves the protein kinase
A (PI"..A)pathway. Whilst activation of the PKC pathway stems from the GnRH
receptor association with the Gq/11Uprotein, the activation of the PKA pathway
occurs when GnRH receptor is associated with the Gsa protein, After binding
of the ligand the recepter-G protein complex exchanges its bound guanosine
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5triphosphate (GTP) for guanosine diphosphate (GOP) and thereby activating
the membrane associated adenylate cyclase. Activated adenylate cyclase
hydrolyses adenosine triphosphate (ATP) to cyclic-adenosine
monophosphate (cAMP). cAMP then acts as a second messenger by
activating or inhibiting various enzymes or cascades by promoting their
phoshorylation or dephosphorylation [21]. A schematic representation of the
above mechanism is shown in figure 1.3.
There is evidence that the GnRH receptor utilises the PKA pathway as a
second messenger in animals. Borgeat, P. et al. (1972) [1] showed that
synthetic GnRH causes the accumulation of cAMP in the anterior pituitary
gland of male rats. Lui, T-C. et al. (1981) [22] also proposed a role for cAMP
in GnRH-dependent receptor regulation via the PKA pathway when they
found that incubation of anterior primary pituitary cells from ovariectomised
rats with cAMP analogues in combination with GnRH caused an increase in
the production and release of LH, compared to primary pituitary cells
incubated only with GnRH. However when Horn, F. et al. (1991) [23]
investigated GnRH receptors in an aT3 cell line (immortalised mouse pituitary
gonadotropes [24]) and th~ir intracellular responses to GnRH analogues,
they found that binding of a GnRH analogue to its receptor did not affect
cAMP levels, but instead increased phosphoinositide turnover and protein
kinase C translocation, suggesting that in aT3 cells the GnRH receptor
preferentially makes use of the PKC rather than the PKA pathway as the
second messenger of choice.
An interesting experiment was performed by Kuphal, O. et al. (1994) [25]
where they stably transfected the GnRH receptor in GH3 cells (a pituitary
lactotrope cell line), now called GGH3 cells. When these cells were stimulated
with GnRH, they found that receptor signalling was dependent on cAMP as a
second messenger, indicating that the GnRH receptor can associate with G
proteins that activate adenylate cyclase. This is in contrast to Saunders, B.D.
et al. (1998) [26], who showed that when GGH3 cells were transfected with
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6various gonadotropin subunit expression vectors, i.e. a-subunit, LHI3 and
FSHI3subunit, GnRH-dependent transcription of these constructs was
Hormone
receptor IJ" AA...AA.~ Acti v.tedIlUr ffl(jne-l.K/pell1J~~l reee
tJutl)p/lQ$pllrJrIjlatloll~CD
G-protein
complex
Adenglate
cgelase
Activated
egel.se
Figure 1.3: A schematic representation of the activation of the PKA pathway. See text for
detail. Figure taken from http:\\www.bgu.ac.il/-aflaloc/bioca/ and is copyrighted to Claude
Aflalo.
mediated via the PKC pathway and that the PKA pathway played no role.
They suggest, however, that the GnRH receptor makes differential use of
signal transduction pathways. In fact this divergence in second messenger
pathways was found when Weiss, J. et al. (1990) [27] investigated the effect
of GnRH stimulation on u-, LHI3-and FSHI3subunit mRNA levels in perfused
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7rat pituitaries. They found a divergence in the regulation of gonadotropin
secretory responses related to the mRNA levels which suggest that different
signalling pathways may be involved in regulating these two cellular events,
i.e. gonodotropin secretion, and changes in mRNA levels of LH and FSH.
Further proof of GnRH's ability to activate both the PKA and PKC pathways
was shown in recent studies by Lin, X. and Conn, P.M. (1998, 1999) [28, 29]
and Han, X. and Conn, M. (1999) [30] done in GGH3 cells. Their results will
be discussed in more detail in section D.
To summarise, it seems that in whole animals or in primary pituitary cells, the
signal transduction pathway used by the GnRH receptor is the PKA pathway.
In aT3 cells the second messenger of choice is the PKC pathway and in
GGH3 cells, both PKA and PKC are used. These apparent differences can be
ascribed to the physiological differences between whole animals, aT3 cells
and GGH3 cells. It may be that the GnRH receptor utilises a different second
messenger pathway depending on the cellular and molecular milieu. The
differences between whole animals, aT3 cells and GGH3 cells will be
discussed in the next section.
B.) Model systems to study regulation of GnRH receptor gene expression
and signalling pathways
There are several model systems which have been used to study regulation
of the GnRH receptor gene, including whole animals, transformed cell lines
originating from tissue types, primary pituitary cells as well as transgenic
animals. When using whole animals, one way to study the effects of the sex
hormones is to remove the negative feedback loop of these steroids on the
pituitary, by way of castration or ovariectomy of mature rats or mice.
Replacement therapy with sex steroids then follows. After an incubation time
the animals are sacrificed and levels of GnRH receptor protein and mRNA
are measured. Cell lines are mostly derived from tumours induced in
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8transgenic mice. The two cell lines most frequently used for GnRH receptor
studies are aT3 and GGH3. The aT3 cell line was made by expressing the
Simian Virus-40 T-antigen (Tag) oncogene linked to the promoter region from
the human a-subunit glycoprotein gene in gonadotrope cells in the anterior
pituitary of transgenic mice [24]. The aT3 clonal cell lines derived from these
tumours express the mouse a-subunit gene and synthesise and secrete the
a-subunit protein, but they are unable to express J3-subunitgenes. GnRH
receptor mRNA and proteins are also found in the same concentration range
as in normal pituitary cells. These receptors also respond to GnRH-
analogues, with dissociation constants similar to those found naturally [23].
Estrogen-, progesterone-, androgen- and glucocorticoid receptors [31] as well
as SF-1 mRNA and protein [7] are all expressed in these cells. On the other
hand, the GGH3 cell line is derived from immortalised lactotrope GH3 cells
from the mouse pituitary, which has been stably transfected with the GnRH
receptor and responds to GnRH or its analogues. Upon activation of the
receptor, prolactin and growth hormone are released, instead of the
gonadotropins FSH and LH, as in normal gonadotrope cells. These cells are
useful for studying the second messenger pathways linked to GnRH receptor
activation [20, 28, 29, 30]. Primary pituitary cells are not often used as they
are difficult to culture and there are often problems with contamination, i.e.
the cells are not all pure gonadotropes.
However, the major difference between cell lines and whole animals is the
fact that cell lines sometimes act as immature of even fetal gonadotropes,
compared to the mature gonadotropes of experimental animals. The clonal
cell lines also sometimes lose some of their differentiated functions. Another
difference is the presence of multiple other factors in whole animals, e.g. rats,
that could work in synergism with steroids and GnRH, but are absent in cell
lines. Nonetheless clonal cell lines have proven to be valid and useful model
systems to study the effects of GnRH and other sex hormones on the
regulation of the GnRH receptor.
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from one animal into another from a different species, e.g. Duval, D.L. et al.
(2000) [32] created GnRH-R/luciferase transgenic mice containing 9100 bp of
the 5'-flanking region of the ovine GnRH receptor gene. The experiments with
transgenic mice are probably nearer to the in vivo state than the transfection
experiments that are usually done in clonal cell lines like aT3 or GGH3 to
determine the importance of cis- and trans- elements in a certain promoter,
but are much more expensive and labour intensive. There is also the problem
of introducing a promoter region from a foreign species that may have a
different transcriptional regulation and therefore will not be compatible with
the transcriptional machinery of the transgenic animal. The added advantage
of using a pituitary cell line such as aT3 cells, is the fact that one can look in
isolation at each different element at a time and see the direct effects that
mutation of these elements have on the activity of the promoter, whilst the
changes seen in transgenic animals may be due to other indirect effects.
Experiments done in clonal cell lines are by far the norm and have yielded
important information which in most cases is consistent with results observed
in whole animals.
c.) Regulation of the GnRH receptor by steroid hormones
The GnRH receptor is a very important protein in the regulation of
reproduction. The regulation of receptor number and mRNA levels can
influence processes that occur further downstream in the hypothalamic-
pituitary-gonadal (HPG) axis (see figure 1.4). Regulation of receptor number
could occur at multiple levels including transcriptional, RNA stability and
transport, translational and post-translational, which could include alterations
in degradation and/or recycling of receptor-ligand complexes. During the rat
estrous cycle, GnRH receptor numbers on the pituitary gonadotropes vary
dramatically in response to a variety of influences, including changes in
levels of estrogen, progesterone and increased GnRH secretion (see next
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section) [33] as well as members of the TGF-13 family of growth and
differentiation factors, i.e. activin and inhibin [34]. Results from various
experiments, grouped together by model system used, will now be reviewed
in more detail.
In animals, estrogen induces a LH surge. Experiments performed by Bauer-
Dantoin, A.C. et al. (1995) [35], in ovariectomised rats, showed that GnRH
receptor mRNA levels are elevated before and throughout this LH surge.
After the peak of the LH surge, GnRH receptor mRNA levels rapidly decrease
and eventually by 24 hours proestrous end at levels lower than before the LH
surge. An interesting observation was the fact that the relative levels of GnRH
receptor mRNA levels showed a strong correlation with numbers of GnRH
receptor protein molecules [35]. Inhibition of hypothalamic input with
pentobarbital treatment blocked the estrogen-induced LH surge and
significantly reduced GnRH receptor mRNA levels. In addition to increasing
the levels of GnRH receptors, estrogen can also sensitise gonadotrophs to
the actions of GnRH by activating the PKC pathway [36]. It was found that
after castration of male rats, their pituitary GnRH receptor concentration
increased by 75 % at 24 hours and the GnRH receptor mRNA levels
increased 5.2-fold after 21 days, while serum LH levels increased 10-fold.
However, treatment with testosterone completely prevented the GnRH
receptor and LH responses to castration. Ovariectomy of female rats also
caused a 2- to 4-fold increase in serum LH levels in the first 3 days, with a
second larger increase of 10- to 15-fold after 5 days. GnRH receptor
concentration increased ± 2-fold on the third day after the operation and
GnRH receptor mRNA levels increased 2-fold after 21 days. Treatment with
estradiol alone, progesterone alone and a combination of progesterone and
estradiol inhibited the increase in GnRH receptor concentration for up to 10
days [37, 38]. The other main female sex steroid, progesterone, had no
stimulatory effect on GnRH receptor mRNA levels during the estrogen-
induced LH surge and even exerted an inhibitory effect on GnRH receptor
mRNA expression at the offset of the LH surge in adult rats [34].
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Taken together these results indicate that the increased pituitary binding of
GnRH is a significant component of the mechanism responsible for
postcastration elevations of gonadotropin secretion and that the regulation of
GnRH receptor number and upregulation of GnRH receptor mRNA
expression at the time of preovulatory LH and FSH surges is probably due to
actions of steroids exerted indirectly through increased GnRH
neurosecretion. In fact Loumaye, E. and Catt, K..J. (1982) [39] observed an
increase in the number of binding sites, i.e. number of GnRH receptors when
they treated primary cultured pituitary cells with GnRH-agonist. Other
evidence by Cho, B.N. et al. (1994) [40] showed that progesterone can
stimulate GnRH gene expression in the hypothalamus of ovariectomised,
estrogen treated adult rats. Chappell, P.E. et al. (2000) [41, 42] further
elucidated the role of the sex steroids on the GnRH surges by showing that
estrogen is in fact the main stimulant and that the progesterone receptor
functions as a estrogen-induced factor whose activation is necessary for the
stimulation of the GnRH surges and that cAMP plays a role in this stimulatory
effect. This may seem in contrast to the findings quoted above that state that
progesterone appears to have an inhibitory effect on GnRH receptor mRNA
expression. However Chappell, P.E. and Levine, J.E. (2000) [41] proposed
that progesterone receptor (PR) trans-activation may initially be stimulated by
a neural signal and be independent of changes in levels of circulating
progesterone. It would also seem likely that pulsatile GnRH neurosecretion
contributes to the maintenance of basal GnRH receptor mRNA expression at
times in the estrous cycle when circulation of gonadal steroids are low [34]. In
conclusion, it seems that the stimulatory effect of estrogen and progesterone
require the presence of a hypothalamic input in the form of increased
pulsatile GnRH secretion.
The results observed in clonal cell lines are not so clear cut as those in whole
animals. McArdle, C.A. et al. (1992) [31] found in aT3 cells that estradiol
alone reduced GnRH receptor numbers. Furthermore, estradiol also reduced
the efficiency of coupling of residual GnRH receptors to second messengers.
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Experiments were also performed in another clonal cell line called L~T2
(gonadotropes), which express LH~, a.-subunit and GnRH receptor mRNA
[43]. These cells respond to pulsatile GnRH administration with LH secretion
and a significant increase in GnRH receptor mRNA, but estradiol alone or in
combination with pulsatile GnRH had no effect on GnRH receptor mRNA
levels. However a combination of estradiol and dexamethasone led to a
dramatic increase of GnRH receptor mRNA. It was also found that the
treatment of these cells with a combination of estradiol and dexamethasone
plus pulsatile GnRH led to an even larger increase in GnRH receptor mRNA
levels [43]. The results for GnRH receptor mRNA levels are consistent with
those obtained in our laboratory, where it was found that estrogen,
progesterone or testosterone alone had no effect on GnRH mRNA levels in
a.T3cells [44]. In conclusion, it would seem that estrogen alone has no effect
on the number and mRNA levels of GnRH receptors in clonal cell lines.
However, when estrogen and pulsatile GnRH are combined, one sees an
increase in GnRH receptor mRNA levels.
In whole animals, however, it appears that the effect of the sex steroids,
estrogen progesterone and testosterone on the GnRH receptor gene are
indirect, i.e. their main mechanism of action is to increase expression and
secretion of certain genes in the hypothalamus. In clonal cell lines this
hypothalamic input is absent and therefore estradiol alone is unable to
increase GnRH receptor levels. As mentioned above, during the estrous
phase, when circulating estrogen and progesterone levels are high, the
increase in GnRH receptor mRNA and protein levels are due to an indirect
effect; estrogen will feedback to the hypothalamus (see figure 1.4) and
stimulate secretion of GnRH. This enhanced secretion of GnRH would then
have a stimulatory effect on its own receptor levels.
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Figure 1.4: A schematic representation of the Hypothalamic-Pituitary-GonadalfAdrenal axis
(HPG and HPA respectively). The trophic peptide hormones GnRH and corticotropin-
releasing factor (CRF) are released from the hypothalamus into the bloodstream. They bind
to their specific receptors in the pituitary and results in the transcription and release of the
gonadotropins LH and FSH, and in the case of CRF in adrenocorticotrophic hormone
(ACTH). LH , FSH and ACTH then travel to their respective target organs, the gonads and
adrenals, and result in the synthesis and release of the steroid hormones. These include
estrogen, progesterone, testosterone and cortisol. The steroid hormones are able to feedback
i.e. they can regulate genes higher up in the axis like the GnRH receptor gene. Steroidogenic
factor-t (SF-1) is expressed in the hypothalamus, pituitary, adrenals and gonads and
regulate genes involved in the above processes (see sections 3,4 and 5). Figure compiled by
G. Styger.
D.) Regulation of the GnRH receptor by GnRH
Thus it would seem that in the regulation of the GnRH receptor gene, its own
ligand, GnRH, plays the most important role. It was shown that in rat pituitary
primary cultures, GnRH receptor is up-regulated by GnRH pulses [12].
Pulsatile GnRH was also found to up-regulate GnRH receptors levels in adult
female rat cultured pituitary cells [39]. Tsutsumi, M. et al. (1993) [45]
performed GnRH binding studies and found that after exposure of aT3 cells
Stellenbosch University http://scholar.sun.ac.za
14
to 10-10or 10-8M GnRH for 20 minutes there was a 50% increase in receptor
number. However despite the increase in receptor number, cytosolic and total
GnRH receptor mRNA levels remained unaltered, but the ability of the mRNA
to direct synthesis of new receptor, was increased about 2-fold. They
concluded that the upregulation of its own receptor by GnRH involves, in part,
modulation of the capacity of cellular mRNA to direct the biosynthesis of
GnRH receptor.
The importance of GnRH pulse amplitude and frequency on GnRH receptor
mRNA levels was investigated in gonadectomised rats with hormone
replacement [46]. In males, GnRH receptor mRNA levels were increased by
3-fold at all pulse levels (5-25 ng/pulse) but only low doses were found to be
effective in females with a 2-fold increase in mRNA levels. Female rats were
more sensitive to changes in the frequency of the GnRH pulse than males.
When pulsatile GnRH was combined with estradiol (in females) the effect was
a synergistic one, once again proving that estrogen can play a role in the
GnRH-stimulated GnRH receptor increase. It was also found that these
increases involve both protein as well as the mRNA levels of the GnRH
receptor in cultured pituitary cells and in whole animals [17]. The results also
suggested that the upregulation was not just a transcriptional effect but also
involves the increase in mRNA activity i.e. a translational effect.
By contrast, continuous treatment of aT3 cells with GnRH or its agonist
reduced GnRH receptor numbers in a time- and dose-dependent manner and
led to a 80% reduction in receptor protein levels. A decrease in GnRH
receptor mRNA levels was also observed, but this was consistently less than
the decline in receptor number [12,47]. Tsutsumi, M. et al. (1995) [48] found
that after exposure to 1 JlMGnRH for 24 hours the number of GnRH receptor
binding sites in aT3 cells decreased to 25% of the control. No corresponding
changes were seen in GnRH receptor mRNA levels, but the ability of cellular
mRNA isolated from aT3 cells to direct the synthesis of functional GnRH
receptor was decreased. The cellular basis for the decrease in GnRH
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receptor levels after continuous GnRH treatment could thus be explained by
a combination of the following mechanisms: down-regulation of GnRH
receptor gene transcription, as well as decreased GnRH receptor mRNA
translation [12, 47, 48].
It is clear from the above that pulsatile GnRH treatment causes an increase in
GnRH receptor protein and mRNA levels, whilst continuous GnRH causes a
decrease in both protein and mRNA levels of the GnRH receptor. The
interesting question remains however: What is the mechanism by which
GnRH regulates the expression of its own receptor? In other words what are
the second messenger pathways responsible for relaying the pulsatile GnRH
signal? The first candidate would be the PKC pathway, involving a influx of
Ca2+ into the cells. Cultured female rat pituitary cells in perfusion given 180-
min pulses of the Ca2+ channel activator BayK 8644 showed a 41% increase
in GnRH receptor mRNA levels, showing that this could be an important step
in the transmission of GnRH pulse signals from the membrane to different
genes including the GnRH receptor gene [17]. Alarid, E.T. et al. (1995) [49]
showed no effect with GnRH and TPA, a phorbol ester and PKC activator, on
GnRH receptor mRNA levels, in aT3 cells, but showed that forskolin
decreased GnRH receptor mRNA levels in a time dependent manner, by
approximately 6-fold in aT3 cells. Forskolin was found, however, not to exert
its effect at the transcriptional level, but rather to decrease mRNA stability.
These results, however, are in direct contrast with those of Lin, X. and Conn,
P.M. (1998, 1999) [28, 29] who found that GnRH activates GnRH receptor
transcriptional activity through multiple signal transduction pathways i.e. the
PKC and Ca2+ pathways and the cAMP-PKA pathway. However, their
experiments were done in GGH3 cells, where the GnRH receptor might be
associated with a different G protein than in aT3 cells, leading to the
activation of different second messenger pathways. A recent study in GGH3
cells by Stanislaus, D. et al. (1998) [11] showed that the GnRH receptor could
associate with Gia, Gsa and Gql11a proteins in a single cell, suggesting that
the GnRH-stimulated increase in GnRH receptor levels could occur via the
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differential use of the different signal transduction pathways. The role of the
PKA and PKC pathways on GnRH receptor gene regulation is discussed in
more detail in section 3D.
2. Structure of the GnRH receptor gene and promoter region
The structures of the mouse [50, 51], rat [5, 52], sheep [53] and human [54,
55] GnRH receptor genes are known and have been cloned. These genes
have a high degree of sequence homology in the coding region, with the
seven transmembrane domains spaced over three exons. However, they
differ dramatically in the sizes of the two introns as well as the sequence and
length of the 5'-untranslated regions (5'-UTR), i.e. regions that are
transcribed, but not translated, as well as the 5'-flanking region i.e.
sequences that are neither transcribed nor translated. The lack of homology
in the 5'-flanking region implies that the GnRH receptor gene could be
regulated differently in each different species. However, many putative cis-
elements are conserved (see figure 1.5), indicating some conservation of
important functional elements. The structures of the GnRH receptor genes
from mouse, rat and human will now be described in more detail, highlighting
the different confirmed cis-elements, established in functional studies, as well
as some putative cis-elements inferred from consensus sequences.
It has been found that the 1.2 kb of the 5'-flanking region of mouse GnRH
receptor gene contains regulatory sequences that direct cell-specific and
GnRH responsive gene expression to the pituitary in vivo. Albarracin, C.T. et
al. (1999) [56] developed a stable transgenic mouse model by linking the 5'-
flanking region of the mouse GnRH receptor to the simian 40 virus T antigen,
and these mice consistently developed tumours in the pituitary. Other
researchers created a transgenic mouse line that contained 1900 bp of 5'-
flanking region from the mouse GnRH receptor gene linked to a luciferase
gene [57]. This 1900 bp was sufficient to direct tissue-specific expression, i.e.
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in pituitary, brain and testis, in the transgenic mice. Luciferase expression
was abrogated after GnRH immunoneutralisation suggesting that one or more
elements conferring GnRH responsiveness are located in this 1900 bp
mGnRH receptor of 5'-flanking region.
Comparison of rat,mouse and human GnRH-R genes
Rat
625 bp 217 bp 1476 bp
1272 bp 219 bp 3300 bp
= Untranslated region I = Transmembrane domain
Figure 1.5: Comparison of the rat, mouse and human GnRH receptor genes, showing the 5'-
flanking or promoter region as well as the three exons and two introns. The figure is not
drawn to scale and is merely given to demonstrate the differences between promoter regions
of the three different species. The relative sizes for the promoter regions are given
underneath each example. The abbreviations are as follows: Pit-1, Pituitary specific response
element 1; CAAT, CAAT box binding element; AP-1, Activator Protein 1 response element;
CRE, cAMP responsive element; SF-1, Steroidogenic Factor 1 recognition site for the mouse
promoter (note that the SF-1 site in the 5'-untranslated region or 5'UTR was previously
known as the Gonadotrope Specific Element (GSE»; TATA, TATA box binding element;
GRAS, GnRH receptor activating sequence and PEA-3, phorbol ester sensitive sequence.
Compiled by G. Styger based on [51].
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The mouse GnRH receptor (mGnRH-R) gene contains three exons with sizes
from 217 bp to 803 bp (see figure 1.5). These are separated by two introns,
with sizes of 15 kb for intron I and 5 kb for intron II [50]. The major
transcriptional start site is situated at position -63 relative to the ATG
translational start site, while two minor transcription start sites were found at -
70 and -106 relative to the ATG codon [58]. Interestingly, no TATA boxes
were found upstream, but it is well known that G-protein coupled receptor
genes often lack such cis-elements. Alternatively, a TCT AA motif and a GATA
motif at -30 in the mGnRH-R gene may fulfil the role of the TATA box.
However Clay, C.M. et al. (1995) [59] found a second major transcription start
site 200 bp (i.e. at -200) upstream of the translation initiation codon, which
may be associated with a TATA box.
The positions of some putative and established cis-elements are shown in
figure 1.5. One of the cis-elements identified by sequence homology includes
a binding site for activating protein-t (AP-1). This has been shown to confer
protein kinase C (PKC) sensitivity to the promoter [60, 61]. Recently another
important regulatory element called the GnRH receptor activating sequence
(GRAS) was identified [621- Currently the protein that binds to this site is still
unknown. There is also no known function for the CAAT element. The
ubiquitous pituitary-specific (Pit 1) response element was also identified by
sequence homology in the 5'-flanking region. Another interesting element is
the gonadotrope-specific element or (GSE). This element is the same as the
SF-1 site located in the 5'-untranslated region (5'-UTR) and was first thought
to playa role in conferring tissue specificity to this gene. The GSE was first
identified in, and thought to be responsible for tissue specific expression of
the a-subunit [7] and LHf3 genes [63, 64, 65]. However, no such site was
found in the FSHf3 gene [66]. The 54-kilodalton protein that binds to the GSE
element in these gonadotropin genes was recently identified as steroidogenic
factor-t (SF-1) [6, 7]. There are two putative SF-1 binding sites in the mouse
GnRH receptor gene promoter, one at position -247 relative to the ATG start
codon and another one at position -14 [58]. The latter site is downstream of
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the transcription start site and therefore situated in the 5'-UTR. Interestingly
there are no consensus cAMP response elements in the promoter region [50,
51]. The cis-elements and transcription factors shown to be involved in
regulating the mouse GnRH-R gene will be discussed in greater detail in
section 3.
The rat GnRH receptor (rGnRH-R) gene also consists of three exons with
sizes of 625, 217 and 1476 nucleotides respectively. The first intron is at
least 12 kb whilst the second intron is only 2.5 kb. The transcriptions start site
is 103 nucleotides upstream of the ATG codon and there is a TATA box near
to it. Sequence analysis data shows that the 1.8 kb 5'-flanking region
contains two SF-1 binding sites, once again one upstream of the transcription
start site and another one downstream in the 5'-UTR, just like in the mouse
promoter (see figure 1.5). There is also an AP-1 site, CAAT boxes, a Pit-1
binding site and a potential cAMP response element (CRE)-like sequence.
The 1.5 kb 5'-flanking region was linked to a luciferase reporter gene and
could be expressed in pituitary aT3 and hypothalamic GT1-7, but not in
kidney COS-7 cells, showing that elements conferring tissue-, but not cell-
specificity were present _in this region [52] in aT3 cells. Forskolin
responsiveness was also present in this region and thought to be mediated
via the putative CRE. However, phorbol esters had no effect, in aT3 cells,
which is surprising considering the presence of a functional AP-1 site [52].
The human GnRH receptor (hGnRH-R) gene has a 5'-UTR of 1272 bp (see
figure 1.5). There are seven TATA and six CAAT sequences in the promoter
region as well as 18 transcriptional start sites [55]. A 1.2 kb of the 5'-flanking
region linked to a luciferase reporter gene could be expressed in human
endometrial tumour cell line (HEC-1A) and human breast tumour (MCF-7),
but not in a mouse aT3 gonadotrope cell line [54]. This inability of the
promoter to drive transcription in the mouse system, suggests the possibility
that this gene is differentially regulated in different species. Several putative
regulatory sequences have also been found on the basis of sequence
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analysis and include sites for PEA-3, a site which is sensitive to phorbol
esters; AP-1 and AP-2, which confer PKC responsiveness, and the pituitary
specific transcription factor (Pit-1). There are also additional putative
recognition sites for the glucorticoid/progesterone- and thyroid hormone
receptors as well as the cyclic adenosine 3'_5' monophosphate (cAMP)
response element binding protein (CREB) [54].
3. Factors interacting with cis-elements in the GnRH receptor promoter
A.) Elements involved in basal and cell-specific expression of the GnRH
receptor gene.
Since most work on regulation of GnRH receptor expression has been done
on the mouse GnRH receptor gene promoter, also the subject of the present
study, most of the evidence presented shall pertain to the mouse model. As
seen above, the promoters of the GnRH receptor genes from different
species, differ in the number and positioning of conserved putative elements,
while some have unique ~Iements not found in other species. One area
where conservation would be probable would be in the elements that confer
cell- and tissue-specificity to the gene. It has previously been shown that
±500 bp of 5'-flanking region of mouse GnRH receptor promoter can bestow
cell-specific expression in aT3 cells and elements responsible for this must
reside in this area [58, 59, 62]. One likely candidate for cell-specific
expression is the gonadotrope-specific element or GSE. In fact the GSE has
been shown to confer pituitary-specific expression to the a-subunit gene in
aT3 cells in conjunction with a pituitary glycoprotein basal element [63]. The
protein that binds to the GSE in vitro was later identified as SF-1 [6, 7] and
such sites were also found in the promoter regions of the GnRH receptor [62]
and LHf3-subunit genes [63, 64, 65]. The above evidence would point to a
possible role for SF-1 in tissue- or cell-specific expression of the GnRH
receptor gene. However Clay, C.M. et al. (1995) [59] and work previously
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done in our laboratory [58] showed that the putative SF-1 site 1, located
immediately upstream of the ATG start codon (see figure 1.6), is not involved
in the regulation of cell-specific activity of the GnRH receptor, but that it might
still playa role in tissue-specificity. Clay and his colleagues suggested that
elements residing between -500 and -200 fulfil the function of cell-specificity.
This area includes the second SF-1-like site (site 2) located at -247 upstream
of the ATG start codon. Work done by Duval, D.L. et al. (1997) [62] showed
that basal activity of the GnRH receptor gene requires elements residing at -
350 to -235. They also found that mutation of this putative SF-1-like site 2
caused a 58% drop in promoter activity.
More recent work by this group [67] identified a tripartite enhancer for the
GnRH receptor gene consisting of the above mentioned SF-1-like site 2, an
Activator protein (AP-1) site, located at -337 to -331, and a novel GnRH
Receptor Activating Sequence (GRAS), located at -392 to -381, with the
following sequence CTAGTCACAACA (see figure 1.6). Mutation of anyone
element alone reduced promoter activity by 60%, while simultaneous
mutation of any two elements reduced promoter activity by 80% and with the
simultaneous mutation of all three elements there was no discernible
promoter activity. It was also found that 3 copies of the GRAS element linked
to a reporter gene were sufficient for cell-specific activity. They thus proposed
that the full basal activity of the GnRH receptor gene promoter requires the
presence of all three elements and that GRAS plays the major role in cell-
specific activity. It is clear then that the SF-1-like site 2 plays an important
role in the regulation of the basal and cell-specific regulation of the GnRH
receptor, but that it acts in concert with the AP-1- and GRAS elements. The
factor that binds to the GRAS element has not yet been identified.
Interestingly, the GRAS element was recently found by the same group to
mediate the response to activin and inhibin [34]. Activin and inhibin are
members of the TGF-J3 family of growth factors, and have been shown to
regulate the levels of GnRH receptor protein and to increase transcription of
the GnRH receptor gene, although the mechanism is not clear. The authors
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showed that 600 bp of the 5'-flanking region of the mouse GnRH receptor
was sufficient to confer activin responsiveness in aT3 cells. They also
showed that mutation of the GRAS element inhibited the ability to respond to
activin.
The basal and cell-specific regulation of the human GnRH receptor (hGnRH-
R) differs slightly from the mouse GnRH receptor gene. None of the three SF-
t-like sites in the hGnRH-R are in close proximity to an AP-1 or GRAS
element. It was found that a SF-1-like site situated at -134 relative to the ATG
start site in the human GnRH receptor promoter was sufficient to mediate cell
specific expression of this gene [68].
Taken together, all the above results show that the basal and cell-specific
expression of the GnRH receptor gene is dependent on a tripartite enhancer
consisting of a DNA-binding site for SF-1 (site 2), an AP-1 binding site and a
GRAS element that is responsive to the actions of activin and inhibin.
However once again the mechanism by which this occurs has not yet been
elucidated. Of the three elements it would also seem that the GRAS element
has the major role to play in cell-specificity.
B.) Elements involved in steroid-dependent expression of the GnRH receptor
gene.
The above scenario represents only the case of basal or unstimulated
expression of the GnRH receptor gene. However as seen in the first section
the GnRH receptor gene may be under control from various steroids as well
as its ligand GnRH. From section 1 C it can be seen that the mechanism
whereby steroids regulate the GnRH receptor gene is not yet clear. One can
thus not say that the effects on GnRH receptor mRNA levels by steroids such
as estradiol are due to a transcriptional effect. These changes in mRNA
levels can merely be due to differences in mRNA stability. If these effects are
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at the transcriptional level, they would be mediated by transcription factors
binding to specific cis-elements in the promoter region of the gene. However
no functional cis-elements for testosterone (T) or progesterone (P) have been
identified for the GnRH receptor promoter for any species. However, Duval,
D.L et al. (2000) [32] recently showed that 9100 bp of the 5'-flanking region
of the ovine GnRH receptor gene was sensitive to treatment with GnRH-
agonist alone and estrogen alone in transgenic mice, but not in aT3 cells. A
2700 bp GnRH receptor promoter transgenic mouse line was also responsive
to these compounds. Thus it does appear that the mouse GnRH-R promoter
contains an as yet unidentified estrogen responsive element within 2700 bp
of the 5'-flank. Although the final picture in the transcriptional regulation of
the GnRH receptor gene by estrogen is still unclear these transgenic mice
could be very useful in further studies.
C.) Elements involved in GnRH-dependent expression of the GnRH receptor
gene.
As described in section 1 D_it appears that GnRH regulates mRNA levels and
synthesis of its own receptor. In section 2, transgenic mouse experiments
have also shown that the mouse GnRH receptor promoter is responsive to
GnRH [57]. Consistent with these results in animals, Lin, X. & Conn, P.M.
(1998) [28] found that in GGH3 cells, GnRH or GnRH-agonist stimulated
reporter activity in a dose-dependant manner. Treatment with cAMP
stimulated reporter activity and pre-treatment of cells with cAMP enhanced
the effect of the GnRH-agonist. A very interesting finding was that treatment
with GnRH-agonist significantly stimulated cAMP release in these cells. They
thus postulated that both GnRH and cAMP activate GnRH receptor
transcriptional activity and that part of the GnRH activation is mediated via
the cAMP pathway.
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They further found that the response elements for GnRH and cAMP reside at
two different sites: between -394 and -318 and between -318 and -1
respectively, relative to the ATG start codon. Their findings are consistent
with the reports above and place the cAMP response element in the region
that contains both SF-1-like sites (-245 to -237 and -15 to -8), and the GnRH
responsive element in the region that contains the AP-1 site at -337 to -331
and a GRAS site at -392 to -381. They suggested that the transcriptional
factors acting via these sites could be involved in mediating the effects of
GnRH and cAMP. Maya-Nunez, G. & Conn, P.M. (1999) [69], also working in
GGH3 cells, reported that the mouse GnRH receptor gene contains a CRE-
like sequence at -107 to -100 similar to one in the protooncogene c-fos
sequence TGACGTTT (see figure 1.6). This putative CRE contains only the
5'-half consensus palindromic sequence and the protein that bound to this
site has not yet been identified. Deletion within this element caused a
complete loss in basal and GnRH-agonist- and forskolin-stimulated
transcription. Maya-Nunez, G. & Conn, P.M. (1999) [69] also identified the
presence of a putative repressor element at -343 to -335 (see figure 1.6).
Deletion of this element increased GnRH receptor promoter activity in basal
and GnRH-agonist-, phor~ol ester-, and forskolin-stimulated GGH3 cells.
From the above evidence it appeared as if elements in the region -392 to
-237 relative to the ATG start codon, plus a newly discovered CRE-like
element as well as a repressor element all played a role in mediating the
GnRH response on the mGnRH receptor gene.
Evidence for the importance of the tripartite enhancer region in response to a
GnRH signal was also found in the aT3 cell line by White, B.R. et al. (1999)
[60] who mutated each component of the tripartite enhancer and found that
GnRH responsiveness was lost only when the AP-1 site was mutated.
Norwitz, E.R. et al. (1999) [70], also using the aT3 cell line, localised the
GnRH responsive elements to two distinct areas and showed that both seem
necessary and sufficient to mediate a full GnRH response. The first element,
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with the sequence 5'=TATGAGTC=3', was named the Sequence Underlying
Responsiveness to GnRH-1 element or SURG-1 and is situated at position
-339 to -332 and overlaps the consensus AP-1 binding site. The second
element SURG-2, with sequence 5'-GCTAATTG-3', lies at -355 to -348 and
appears to be novel (see figure 1.6). Interestingly, studies done on the human
GnRH receptor gene in aT3 cells [61] showed that the transcriptional down
regulation of the hGnRH-R gene by GnRH is mediated via two putative AP-1
sites in the promoter region. They also show that the activation of the PKC
pathway is important in controlling hGnRH-R gene expression in aT3 cells.
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Figure 1.6: Schematic representation of 400 basepairs of the mouse GnRH receptor gene
promoter. The scheme is drawn to seale and shows the positioning of the major cis-elements
involved in basal- and GnRH-dependent expression of the mGnRH-R gene. All elements are
numbered relative to the ATG start codon. Underneath the scheme the actual positions of the
elements are indicated, i.e. the ATG or translational start site at position +1 [50], the SF-1
like site 1 at position -14 to -8 [50], the major transcriptional start site at position -63 [58], the
putative eRE-like sequence at position -107 to -100 [69], the second SF-1 site at position
-247 to -237 [67], the AP-1 site at -337 to - 331 [67] and the GRAS element at position -392
to -381 [67]. Also indicated is the repressor element found in position -343 to -335 [69J, as
well as the two SURG elements found at positions -339 to -332 (no. 1) and -355 to -348 (no.
2) [70]. Figure compiled by G. Styger from information in above references.
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The summary of all the above results would be that GnRH-dependent
transcriptional regulation of the mGnRH receptor gene involves several
elements in the promoter region of this gene. From the work by Lin, X. &
Conn, P.M. (1998) [28] it would seem that the region containing the tripartite
enhancer plays a role in this regard. Evidence was also given that the PKA
pathway is involved via a putative CRE-like element [69]. All of the above
experiments were however performed in the GGH3 cell line. Other
experiments done in aT3 cells [60, 70] showed that the AP-1 site, together
with the SURG-1 and SURG-2 elements are the important elements in the
mediation of the GnRH response. The issue of which second messenger
pathway is used to mediate the GnRH response will be reviewed in more
detail in the next section.
D.) The roles of the PKA and PKC/Ca2+ signal transduction pathways in
GnRH-dependent regulation of the GnRH receptor gene
The roles that the major signal transduction pathways i.e. PKC/Ca2+ and PKA
play in the regulation ot GnRH receptor gene transcription is a very
complicated issue. Lin, X. & Conn, P.M. (1998) [28] and Maya-Nunez, G. &
Conn, P.M. (1999) [69] found that the major second messenger pathway
involved in GnRH-dependent GnRH receptor gene regulation is the PKA
pathway. It is nonetheless important to remember that both of the above
groups make use of the GGH3 cell line. These cells are not natural
gonadotropes, but rather somatolactotropes stably transfected with the GnRH
receptor gene. They express the GnRH receptor on their cell surfaces, but
may well lack other internal factors that play a role in gonadatrape specific
expression like SF-1 or other nuclear receptors. Evidence pointing to the
importance of the PKC pathway was found by Norwitz, E.R. et al. (1999) [70]
and Cheng, K.W. et al. (2000) [61] and their data suggest that the response
of the mouse and the human GnRH receptor gene to GnRH is mediated via
the PKC and not the PKA. pathway. These authors made use of the aT3 cell
Stellenbosch University http://scholar.sun.ac.za
27
line in their experiments and the seemingly contrary evidence concerning the
PKA vs. PKC pathways could possibly be explained by the differences
between the two cell lines (GGH3 vs aT3).
Perhaps the most plausible scenario is the one suggested by Lin, X. and
Conn, P.M. (1999) [29] who propose that GnRH activates transcription of the
GnRH receptor gene through both the PKA and PKC and Ca2+ pathways in
GGH3 cells. Some of the evidence they present is that the activation of PKC
significantly stimulated reporter activity, whilst inhibition of PKC or PKC
depletion blocked PKC- or GnRH-agonist stimulation of the GnRH receptor
promoter. Also, GnRH-agonist stimulated reporter activity was inhibited by
preventing the external Ca2+ influx with EGTA, or Ca2+ ion channel antagonist
0600. They also find that the MAPK pathway is involved in repression of
basal activity and GnRH-agonist stimulated GnRH receptor promoter activity.
The mechanism of repression of basal activity is unknown but it might be due
to phosphorylation of a repressor transcription factor. White, B.R. et al.
(1999) [60] and Norwitz, E.R. et al. (1999) [70] found that ERK kinases partly
mediate the GnRH regulation of the GnRH receptor gene in aT3 cells.
Furthermore, members of the Fos/Jun heterodimer superfamily are part of the
protein complex formed on SURG-2 and these proteins are induced by GnRH
stimulation.
As can be seen the regulation of transcription of the GnRH receptor gene is a
very complex situation where multiple factors and cis- and trans-elements
playa part. In summary it can be said that the basal, unstimulated expression
of the GnRH receptor gene involves a tripartite basal enhancer consisting of
an AP-1, SF-1-like (site 2) and GRAS element. The SF-like site 1 seems to
be unimportant in basal expression, however some constructs used may not
have contained a complete site 1 (see conclusions). It is still unclear which of
these three elements confer tissue- or cell specificity, but the GRAS element
seems to play the major role in this regard. The AP-1 site and nearby novel
elements SURG-1 and SURG-2 are the prime candidates for conferring
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GnRH responsiveness to the gene, as mutation of these sites cause the
GnRH receptor gene to be insensitive to GnRH. Lastly the second messenger
pathway involved in the GnRH signal transduction appears to be the PKA
pathway in GGH3 cells, while the PKC/Ca2+ pathway takes precedence in aT3
cells. This has however not been clearly established and the possibility that
the GnRH signal involves the differential use of both pathways remains.
Whatever the case may be, the PKA response element identified as a
putative CRE site is likely to playa role. However, this site has yet to be
proven to be functionally recognised by any factor. Even if the GnRH-
dependent regulation of GnRH receptor gene transcription is mediated solely
by PKC in aT3 cells, the possibility exists that the gene is regulated by the
PKA pathway via other signalling molecules. The PKC response element was
clearly identified as the AP-1 and SURG-1 and SURG-2 elements. The
presence of a repressor element was also investigated, but whether this
element has a physiological role to play remains to be seen. Of course the
regulation of a single gene cannot be looked at in isolation and will depend
on a variety of other factors. For example the manner by which regulation of
the GnRH receptor gene is achieved, is likely to be dependent on other
external factors such as de~elopmental stage, steroid milieu, stress condition,
health condition and a myriad of other factors. It is however clear that SF-1
protein plays a pivotal role, together with various other factors, in the
transcriptional regulation of the GnRH receptor. In the next section the role of
SF-1 in gene regulation will be reviewed in more detail.
4. The role of SF-1 in gene regulation
Steroidogenic factor 1 (SF-1) was first discovered as a key regulator of
steroidogenic enzyme gene expression and was also called adrenal 4-binding
protein or Ad4BP, because it was identified as the protein that bound to the
Ad4 cis-element of the bovine cytochrome P-450(11f3) gene (CYP11B) [71].
The protein was called steroidogenic factor because it was first found only in
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steroidogenic cells and thought to play an important part in the cell-specific
expression of the cytochrome P-450 steroid hydroxylase genes. SF-1 protein
was purified and it's cDNA isolated by two independent groups; Lala, D.S. et
al. (1992) [72] from the mouse and by Honda, S. et al. (1993) [71] from bovine
tissue. They both identified a 53 kilodalton protein and a 1383 bp cDNA that
encoded for a protein of 461 amino acids.
From the cDNA sequence it was discovered that SF-1 was a member of the
nuclear receptor superfamily, the members of which include the
glucocorticoid, mineralcorticoid, progesterone, androgen, estrogen, thyroid
hormone, and retinoid X receptors [73]. These proteins have conserved
functional domains that include two zinc fingers, a proline rich domain
(proposed to mediate transcriptional activation), a potential site for
phosphorylation by cAMP-dependent protein kinase and an AF-2
transactivation domain [74]. SF-1 is a member of the family of orphan nuclear
receptors. These are receptors that have no identified ligand and are possibly
regulated by other means, and also include the transcription factors COUP-
TF and NUR-77 [7]. Another surprise was that the cDNA showed homology
to the mammalian homologue of the Drosophilia transcription factor fushi
tarazu-factor 1 or FTZ-F1 that regulates the fushi tarazu gene, as well as
embryonal long terminal repeat-binding protein (ELP) which is expressed in
mouse embryonal carcinoma cells [71, 72, 74]. Characterisation of the mouse
FTZ-F1 gene by Ikeda, Y. et al. (1993) [75] showed that both SF-1 and ELP
are encoded by the same gene and that there are shared exons encoding
common regions and alternative promoter and 3'-exons which give rise to the
differences between the two transcripts.
To further understand the role of SF-1 in steroidogenesis the spatial and
temporal developmental profile of SF-1 expression was studied. Ikeda, Y. et
al. (1994) [76] found SF-1 transcripts in the urogenital ridge, the precursor of
the gonads, adrenal glands and kidneys, at embryonic day 9 (E9). By E11
when the adrenals and gonads are clearly separate, SF-1 was present in the
adrenal primordium and the genital ridge. By E12.5 to E13.5, SF-1 transcripts
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were localised in the outer cortical region of the adrenal gland [74, 77] and
after sexual differentiation, about E14, SF-1 was significantly expressed in
the Leydig and Sertoli cells of the testis, but there was almost no expression
in the ovaries [78]. SF-1 was also found in the embryonic forebrain, later to
become the hypothalamus and pituitary, suggesting that it plays a more
global role in the hypothalamic-pituitary-gonadalladrenal axis than simply
regulating steroidogenesis.
Evidence for the above statement was obtained when the role of SF-1 in vivo
was investigated using FTZ-F 1 knockout mice. Luo, X. et al. (1994) [79]
created chimerical animals by targeted disruption of the Ftz-F1 gene. They
show that -1- knockout animals were born at the expected frequency of 25%,
indicating that SF-1 is not required for embryonic survival [77]. However all
the -1- animals had external female genitalia, irrespective of genetic sex, a
failure to produce testicular androgens, [74, 77] and died shortly after birth
due to corticosteroid deficiency, indicating the important role that SF-1 plays
in androgen and corticosteroid biosynthesis. A very interesting observation
about these -1- animals was that their adrenal glands and gonads were
completely absent, once a,gain revealing the key role that SF-1 plays, not
only in steroidogenesis, but also in the development of these tissues [74, 77,
79].
As SF-1 was also found to be expressed in the embryonic forebrain and later
in the hypothalamus and anterior pituitary, it suggested that further
abnormalities would be likely to occur in these animals. Ingraham, H.A. et al.
(1994) [6] found that the pituitaries of the knockout mice were devoid of LH,
FSH and GnRH receptor protein and mRNA which are all classical markers
for gonadotropes. Indeed Asa, S.L. et al. (1996) [80] showed that SF-1 is
preferentially expressed in gonadotrope cells of the pituitary. These animals
also lacked the ventromedial hypothalamic nucleus, a region that contains
high concentrations of steroid hormone receptors and has been implicated in
female reproductive behaviour [77]. In another study the spleen of knockout
mice showed severe developmental defects, i.e. impaired splenic vascular
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architecture [81]. From these results it became apparent that SF-1 plays an
important role in steroidal and gonadal development and regulation, and is
not only involved the transcriptional regulation of the steroidogenic enzyme
genes.
One explanation for the absence of LH, FSH and GnRH receptor protein and
mRNA in the pituitary of SF-1 knockout mice can be gleaned from promoter
analysis of these genes. Experimental analysis showed that SF-1 protein
interacts with certain elements on the gene promoter regions of the a-subunit
of the gonadotropin hormones [6, 7] and the LH~ subunit [63, 64, 65] as well
as the GnRH receptor [62, 68] and regulates their expression. However it was
found that treatment of the SF-1 knockout mice with GnRH restored the
pituitary expression of LH and FSH, [74] suggesting that SF-1 is not essential
for gonadotropin and GnRH receptor expression. This however raised the
possibility that SF-1 acts not only on the gonadal/adrenal and pituitary levels
of the HPG/HPA axis, but also at the hypothalamic level. The absence of SF-
1 in these knockout mice did not influence the normal numbers and location
of GnRH neurons [82], but might interfere with GnRH expression, secretion or
delivery to the pituitary. This disruption in GnRH together with the fact that
SF-1 plays a direct role in transcription of the gonadotropin and GnRH
receptor genes, may explain why treatment with GnRH can only partially
restore LH and FSH expression. This still does not explain why one can
partially restore LH and FSH expression, when SF-1 is absent, since SF-1 is
supposed to be very important for tissue-specific expression of these genes.
One possible explanation might be that SF-1 can be substituted for by other
orphan nuclear receptor family members.
It is thus well established that SF-1 is a key regulator at all levels of the
HPG/HPA axis and that the absence of SF-1 results in serious developmental
defects and the lack of expression of important genes. The question of which
genes SF-1 regulates and the mechanism thereof will now be examined in
more detail.
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5. Gene regulation by SF-1
A) The genes regulated by SF-1
Since SF-1 was first discovered as a regulator of the steroidogenic enzyme
genes, most studies pertaining to SF-1 binding to DNA have been performed
on these genes. It is well established that most members of the nuclear
receptor superfamily bind to DNA in one of two ways, i.e. by direct or
inverted dimerization. This means that the binding site consists of either
directly repeated or inversely repeated half-sites, allowing the binding of two
receptors next to each other. However SF-1 and its close relative Nur-77,
bind to DNA as monomers, resulting in a third paradigm of nuclear receptor-
DNA interaction [83].
SF-1 DNA-binding sites have been identified and shown to be functional in
several promoters of genes involved in steroidogenesis (see figure 1.7) , i.e.:
the cytochrome P450 aromatase gene [84, 85, 86, 87, 88], the cytochrome
P450 side-chain cleavage gene [89, 90, 91l, the gene encoding cytochrome
P450 steroid 17a-hydroxylas~/c17-20 lyase [92,93,94] and the steroidogenic
acute regulatory (StAR) protein gene [95, 96, 97, 98] as well as the high
density lipoprotein receptor, which mediates the uptake of cholesterol and
cholesteryl esters, the substrates for steroidogenesis [99]. For most of these
promoters, there is strong evidence that SF-1 protein is the transcription
factor which mediates the response via the SF-1 cis-element.
As mentioned in section 4, SF-1 protein was later found to not just regulate
the steroidogenic enzyme genes, but a variety of other genes as well. One of
the effects of SF-1 knockout mice was that all animals had external female
genitalia, suggesting that SF-1 protein played a role in the sex determination
cascade that takes place shortly after testis development. A very important
link in this cascade is Mullerian inhibiting substance or MIS. MIS is secreted
by the Sertoli cells of the testis, causing cell-death of the Mullerian duct and
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development of external male genitalia. SF-1 protein was found to bind to
elements in the promoter region of the MIS gene [100, 101]. SF-1 protein was
also found to be essential for basal transcription of the humanACTH receptor
gene [102] and the oxytocin gene in the bovine ovary [103], as well as the
gonadotropin a-subunit and LH~-subunit and GnRH receptor genes in the
pituitary gonadotropes, mentioned in section 3A. Additionally SF-1 cis-
elements have been found to be positive regulators of rat granulosa cell
differentiation and negative regulators of mitosis [104].
SF-1 and other nuclear receptor binding sites
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Figure 1.7: The DNA-binding sites for SF-1 and other nuclear receptors. The consensus
DNA-binding sites for SF-1 are shown for various genes, including the GnRH receptor [50],
aromatase [84, 85, 86, 87, 881, steroid 21-hydroxylase [92, 93, 94], cho!esterol side-chain
cleavage [89, 90, 91] and ce-subunit genes [6, 7}. The SF-1 site 1 is shown for the mouse
gene, the sequence of site 2 is TGGCCTTC.A.. For the rat, SF-1 site 1 is shown, the sequence
of site 2 is TGGCCTTCA [52}. The human SF-1 site 1 is also shown, the sequence for site 2
is TATCCTTAA and for site 3, TTTCCTTGA [54]. The DNA-binding sites for other nuclear
receptors i.e. ERE, COUP- TF and NUR-77 are shown to indicate the close sequence
homology in the different binding sites. Figure adapted by G. Styger from [58].
Stellenbosch University http://scholar.sun.ac.za
34
B.) The effect of SF-1 on tissue specific expression
The fact that SF-1 protein is widely expressed in steroidogenic tissues led
many to believe that it played a role in tissue-specific expression of the
various steroidogenic enzyme genes. Some evidence for this exists. Lynch,
J.P. et al. (1993) [84] found that the SF-1 site in the rat aromatase promoter
acts as a cell-selective regulatory element. Other evidence for a tissue-
specific role for SF-1 has been found in the human cytochrome P450 side-
chain cleavage gene. This promoter was inactive when transfected into
nonsteroidogenic cells, but could be activated by the expression of
exogenous SF-1 [91]. This indicates that SF-1 protein also plays a role in
conferring tissue specificity to this gene. However as it is now known that SF-
1 is expressed in many tissues, and not just the steroidogenic tissues, it is
clearly not the main factor that determines whether a certain gene is
expressed in a certain tissue. The above statement is corroborated by the
examples of the gonadotropin genes, LH and FSH. The a-subunit [6, 7] and
the LHp-subunit [63, 64, 65] both have a GSE or gonadotrope specific
element, that was thought to confer tissue-specificity to these genes. This
GSE element was later identified as a SF-1 DNA-binding site in vitro. If SF-1
protein was the only regulator of tissue-specific expression of these genes,
they would not only be expressed in the pituitary, but in the adrenals and
gonads as well, because SF-1 protein is present in these tissues. SF-1
protein probably acts in combination with other tissue specific factors to
confer tissue-specificity. This is certainly the case with the GnRH receptor
gene [67].
C.) The relationship between SF-1 and the PKA pathway
We can thus see that SF-1 protein plays an important role in tissue-specific
regulation of certain genes. Another area where SF-1 protein seems to be
involved is in mediating the PKA response to certain genes, i.e. SF-1 protein
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is necessary for the PKA pathway-dependent increase in transcription of
certain genes. The mechanism whereby SF-1 protein mediates the PKA
response can be either a direct or an indirect effect. The latter would be the
case when the PKA pathway changed the levels of SF-1 protein or the affinity
of SF-1 for DNA binding. Evidence for this indirect effect was obtained by
Shapiro, O.B. et al. (1996) [104] when they found that incubation of rat
granulosa cells with 8-Sr-cAMP (a cAMP analogue) induced a 2-fold increase
in SF-1 mRNA Michael, M. D. et al. (1995) [87] found that nuclear extracts
isolated from forskolin treated bovine luteal cells, showed a 4-fold increase in
binding of a SF-1 DNA-binding sequence probe. This increased binding was
unlikely to be due solely to an increase in SF-1 transcription as SF-1 mRNA
levels increased by only approximately 2.5-fold over basal. It was postulated
that SF-1 protein may be post-translationally modified in response to
stimulation of the PKA pathway. Other factors can also increase SF-1 mRNA
levels e.g. GnRH. It has been found that GnRH regulates expression of the
SF-1 gene in the pituitary, with pulsatile administration of GnRH giving 60%
increases in SF-1 mRNA levels [105]. On the other hand, a direct effect would
be something like direct phosphorylation of SF-1 by the PKA pathway,
leading to increased binding and promoter activity. Transfection experiments
done by Zhang, P. & Mellon, S.H. (1996) [93], in mouse Leydig MA-10 and
adrenocortical Y-1 cell lines, showed that SF-1 protein can bind to an
element in the promoter of the cytochrome P450 17a-hydroxylase/c17 -20
lyase gene and that SF-1 mediates the stimulatory effect of the PKA pathway
on transcriptional activity. What is more, they showed that SF-1 protein can
be directly phosphorylated by PKA at serine and threonine residues. Further
work on the direct effect of the PKA pathway on SF-1 was done by Jacob,
AL. & Lund, J. (1998) [94] when they found that mutations in the carboxy
terminal AF-2 transactivation core domain of SF-1 dominantly suppressed the
PKA-dependent transactivation of the bovine cytochrome P450 17a-
hydroxylase/c17-20 lyase gene. It could also be that SF-1 protein is not the
only protein involved and that there are cofactors involved e.g. cAMP
response element binding (CREB) protein, which is directly targeted for
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phosphorylation or dephosphorylation. The mechanism of SF-1 mediation of
the PKA pathway on different genes will now be review in more detail.
In addition to the SF-1 DNA-binding site in the rat aromatase gene promoter,
Fitzpatrick, S.L. & Richards, J.S. (1994) [85] found a cAMP response element
about 80 basepairs upstream and showed that both these elements were
required for transcriptional activation by PKA. Later evidence [86] positively
identified the protein that bound to this CRE-like element as CREB (CRE
binding protein). However the human aromatase gene promoter has been
found to be regulated in a different manner compared to the rat promoter.
Michael, M.D. ef al. (1995) [87] found no classical CRE elements in the
promoter region and the area crucial for cAMP responsiveness converged
exactly with the SF-1 DNA-binding element. They concluded that PKA-
stimulated transcription of the human aromatase gene in the ovary is due to
increased levels and DNA binding activity of SF-1. Clemens, J.W. ef al.
(1994) [89] found two SF-1 DNA-binding sites in the promoter area of the rat
cytochrome P-450 cholesterol side-chain cleavage gene and showed that SF-
1 protein indeed bound to these sites. Chau, Y.M. ef al. (1997) [90] found that
simultaneous mutation of these two SF-1 binding sites caused a 7-fold
decrease in basal transcriptional activity, but that the decrease in torskolin-
stimulated transcriptional activity was only minor. It was therefore postulated
that SF-1 does not playa major or direct role in the cAMP or PKA pathway
activation of this particular gene.
The other major steroidogenic enzyme gene regulated by SF-1 is the
steroidogenic acute regulatory protein or StAR. This protein plays a critical
role in the first step in steroid hormone synthesis i.e. the conversion of
cholesterol to pregnenolone. Sugawara, T. ef al. (1997) [95] found a proximal
SF-1 DNA-binding element, with the sequence TATCCTIGAC, in the human
StAR gene and showed that this sequence confers responsiveness to cAMP
in the presence of SF-1. A second more distal SF-1 DNA-binding site was
also identified near the transcriptional start site, with the sequence
CAGCCTIC, and the same properties as the first site i.e. responsiveness to
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PKA. They further found that mutation of either site drastically reduced basal
and cAMP-stimulated promoter activity, but that the more proximal site had
more pronounced effects. Therefore both SF-1 sites seem to be required for
both basal and cAMP-activated StAR promoter activity. A third SF-1 DNA-
binding site was found further upstream but was not implicated in the PKA
response. Exactly the same results were also obtained when the rat [96] and
mouse [97] StAR gene promoters were investigated. Further studies done by
Clark, B.J. & Combs, R. (1999) [98] on the human promoter indicated that
transcriptional activation of the StAR gene by a SF-1-dependent mechanisms
could represent a common pathway for ACTH (via the PKA pathway) and
angiotensin " action in stimulating steroid production in both the adrenal
fasiculata and glomerulosa. Evidence was also found that SF-1 plays a role in
mediating the cAMP regulation of the high density lipoprotein receptor, which
mediates the uptake of cholesterol and cholesteryl esters; the substrates for
steroidogenesis [99].
In conclusion it would seem that the exact mechanism whereby SF-1 protein
mediates the PKA response differs from gene to gene and can even differ for
the same gene between spe~ies. In the rat aromatase gene SF-1 protein and
CREB protein seem to work together to mediate the PKA response, whilst the
human aromatase gene contains no CRE elements and the PKA response is
mediated by SF-1 protein alone. The rat cytochrome P-450 cholesterol side-
chain cleavage gene on the other hand contains two SF-1 DNA binding sites,
but neither of them play any role in mediating the PKA response. The PKA
response in the rat, mouse and human StAR gene are all mediated by their
two SF-1 DNA-binding sites. The one conclusion that can be drawn from all
the above evidence is that although it is very difficult to predict the exact
mechanism whereby SF-1 mediates the PKA response in a certain gene, for
several genes there is strong evidence that it plays a direct or indirect role.
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D.) Interaction between SF-1 and other proteins: protein-protein interactions
We can thus see that SF-1 protein controls a wide array of genes, both those
involved in steroidogenesis and other functions. In some cases it has been
shown that SF-1 protein directly interacts with other proteins to regulate the
expression of a certain gene. Monte, D. et al. (1998) [91] found that SF-1
protein interacts with exogenous p300 and CREB-binding protein (CBP) in
the human cytochrome P450 side-chain cleavage gene. These are closely
related ubiquitous coactivators that possibly bridge transcriptional activators
and the components of the basal transcriptional apparatus. Another protein
that was found to directly interact with SF-1 is the early growth response-1
(ERG-1) protein. Dorn, C. et al. (1999) [65] found that the synergy between
ERG-1 and SF-1 is required for activation of the LH p-subunit gene by
gonadotropin-releasing hormone. They also found that the direct protein-
protein interaction requires the zinc-finger domain of ERG-1. One of the best
known examples of a protein that interacts directly with SF-1 protein is the
orphan nuclear receptor DAX-1 (see section 5 F) [106].
E.) Competition for DNA-binding sites between SF-1 and other proteins
Some proteins compete with SF-1 for the same or overlapping DNA-binding
sites. Bakke, M. & Lund, J. (1995) [92] identified an element in the bovine
cytochrome P450 steroid 17a-hydroxylase gene that contained the repeated
sequences AAGTCA and AGGTCA interspersed by six nucleotides. SF-1 was
shown to bind to this sequence and was able to mediate the PKA-stimulated
transcription. However another orphan nuclear receptor, chicken ovalbumin
upstream promoter transcription factor or COUP-TF also bound to this
sequence and repressed SF-1-dependent activation of the gene. This was
accomplished by the fact that the two receptors bound in a mutually exclusive
manner to the above element. The oxytocin receptor also contains these six
basepair repeats and it was found that SF-1 was bound to this element when
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the promoter was active, but that COUP-TF occupied this site when the
promoter was inactive [103]. The above scenario also takes place in the
stimulation of cytochrome P450 aromatase promoter activity in endometriosis
tissue and its inhibition in endometrium tissue, due to the competitive binding
of SF-1 and COUP-TF to the same cis-acting element [88].The competitive
binding of SF-1 and COUP-TF seems to be a general way of regulating or
controlling the effects of SF-1, where binding of SF-1 causes transcriptional
activation and the binding of COUP-TF to the same element causes the
promoter to become inactive. The exact mechanism is still unknown, but one
can postulate that the relative concentrations of the factors could be
regulated to determine which factor binds predominantly.
F.) The role of DAX-1
No discussion on SF-1 control can be complete without a discussion on DAX-
1. DAX-1 is also an orphan nuclear receptor and was first discovered and
isolated as the gene that caused X-linked adrenal hypoplasia congenita
(AHC) and hypogonadoptropic hypogonadism (HHG), both diseases with
phenotypes similar to those of SF-1 knockout animals [74, 108]. DAX-1 thus
stands for Dosage-sensitive sex reversal-Adrenal hypoplasia congenita
critical region on the X chromosome. It is a novel member of the nuclear
receptor superfamily, because it lacks the typical zinc finger DNA binding
motifs. The demonstration of DAX-1 expression in the hypothalamus and
pituitary and the phenotypical similarities between SF-1 knockout and DAX-1
mutation suggested that SF-1 and DAX act sequentially in a hierarchical
pathway or that the two proteins interact directly to regulate target genes. The
latter hypothesis was proven to be true when Ito, M. et al. (1997) [106]
showed that coexpression of SF-1 and DAX-1 led to an inhibition of SF-1-
mediated transcription. They also showed with in vitro protein binding studies
that DAX-1 interacted directly with SF-1, but that the ability of SF-1 to bind to
DNA was not affected. Further investigation by Crawford, P.A. et al. (1998)
[109] showed that this interaction occurs through a repressive domain within
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the carboxy terminus of SF-1. Also they demonstrate that DAX-1 recruits
nuclear receptor co-repressor N-Cor to SF-1. However Lalli, E. ef al. (1998)
[110] could not detect an in vivo association between DAX-1 and SF-1 and
instead found that DAX-1 binds to hairpin DNA structures. Deletion of these
structures removed DAX-1 capacity to repress transactivation by SF-1. They
further propose a model whereby the binding of DAX-1 to DNA results in the
down-regulation of SF-1-mediated transactivation by recruitment of the
transcriptional silencing domain residing in the DAX-1 C-terminus. It is
difficult to reconcile these two divergent findings. It is however possible that
the multiple SF-1 DNA-binding sites (most genes regulated by SF-1 have at
least two of these SF-1 DNA-binding sites situated around 180-200 base
pairs from each other) could associate with each other to form such DNA
hairpin structures. This may enable DAX-1 (if present) to bind to the DNA
secondary structure and simultaneously bind to the SF-1 proteins bound to
the DNA, thus repressing the transactivation by SF-1.
6. The role of 25-hydroxycholesterol
As seen above, SF-1 plays diverse roles in regulating various steroidogenic
and other genes through out the HPG/HPA axis. The unresolved question
however still remains: Is SF-1-dependent transcriptional activity modulated by
a ligand, either endogenous to steroidogenic cells, or supplied in an
endocrine fashion? Lala, D.S. ef al. (1997) [111] showed that 25-, 26- or 27-
hydroxycholesterol, all suppressers of cholesterol biosynthesis, increased
SF-1-dependent transcriptional activity. The activation is dependent upon SF-
t's AF-2 domain and it is specific for SF-1. Recently LXR, another nuclear
receptor was shown to be responsive to 22-hydroxycholesterol and these
results suggest that oxysterols may mediate transcriptional activation via
different intracellular receptors [112]. However these previous experiments
were performed in non-steroidogenic cells. Mellon, S.H. & Bair, S.R. (1998)
[113] used a mouse steroidogenic Leydig cell line MA-10 to determine if 25-
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hydroxycholesterol could act as ligand in this milieu. The results indicated
that oxysterols are not ligands for SF-1 in these cells and that transcription of
six different SF-1-responsive genes was unaffected by the presence of 25-
hydroxycholesterol. The question however still remains as to the role that
these oxysterols play in non-steroidogenic tissues, i.e. the pituitary and the
hypothalamus. It is still possible that SF-1 is regulated differently in different
tissue types, and that there might be more than one, yet to be discovered,
ligand that controls SF-1-dependent transcription in steroidogenic cells.
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CHAPTER2
MATERIALS AND METHODS
1. Buffers and reagents
All reagents and buffers were made up with distilled water or deionised
(MilliQ) water and sterilised by autoclaving or sterile filtration. All materials
i.e. powders and organic solvents used were analytical grade, unless stated
otherwise.
2. Plasmids
A genomic clone of the mouse GnRH receptor gene was obtained from Stuart
Sealfon at Mt. Sinai in New York. This clone contained 1.1 kb of the GnRH
receptor gene cloned into the pBluescript®SK phagemid. After mutagenesis
of the ATG start codon to a Bgl /I site, a 580 bp Bgl II/BamHI fragment,
spanning from -580 to +1 relative to the ATG codon, was excised and cloned
into the Bgl /I site of the promateriess luciferase (LUC) reporter plasmid,
pGL2-basic (Promega) [58] to yield plasmid LG. The putative SF-1-like site 1
was also mutated from TGTCCTTGG to TG I I I I 1GG by Carmen Pheiffer
[58] to yield plasmid LGM1. The p-galactosidase expression vector
pCISLACZ, used as a control for transfectional efficiency, was provided by
Dr. Sue Kidson, Department of Anatomy and Cell Biology, University of Cape
Town Medical School. This plasmid has the lacZ gene (3.8 kb) cloned into the
Xhol/Smal site of the 6.27 kb pCIS vector. The GnRH-R plasmid (R10) which
contains the full length cDNA for the mouse GnRH receptor (1.2 kb), cloned
into the EcoRllXhol site of the cDNA IIAmp vector (4.8 kb), was obtained from
Janet Hapgood, University of Stellenbosch (originally from R.P. Miller,
Department of Chemical Pathology, University of Cape Town Medical
School). Human p-actin cDNA (2.1 kb) cloned into the BamHI site of the 2.9
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kb ampicillin resistant expression vector Okayama-Berg [114] was provided
by Iqbal Parker, Department of Medical Biochemistry, University of Cape
Town Medical School.
3. Oligonucleotides
The sequences of the oligonucleotides used are listed below:
Oligonucleotides used for mutagenesis and sequencing
GL1 5' TGTATCn ATGGTACTGTAACTG 3'
GL2 5' cmATG I I I I IGGCGTCnCCA 3'
115 5' AGGGGCTACGGTTACACTGCAGCnCAGGAGGGCnGGC 3'
116 5' GCCAAGCCCTCCTGAAGCTGCAGTGTAACCGTAGCCCCT 3'
4. Plasmid isolation
4.1 Extraction of plasmid QNAby the Wizard Maxiprep DNA Purification
system
The protocol used was in accordance with the manufacturer (Promega). A
single colony of transformed bacteria (see section 12) was used to inoculate
10-30 ml of Luria broth (LB, see appendix A). These starter cultures were
incubated overnight at 37°C in the presence of 50 !lg/ml ampicillin. The
following day 500 ml of LB was inoculated with 10 ml of the starter culture
and incubated at 37°C overnight with constant agitation in the presence of
50 !lg/ml ampicillin.
100 - 500 ml cells were pelleted by centrifugation at 5 000 x g for 10 minutes
at 22° - 25° C. The cell pellet was completely resuspended in 15 ml Cell
Resuspension Solution (50 mM Tris-HCI (pH 7.5), 10 mM EDTA, 100 !lg/ml
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RNase A), with the aid of manual disruption. The cells were lysed by adding
15 ml of Cell Lysis Solution (0.2 M NaOH, 1% (w/v) SOS) and inverting the
tube for up to 20 minutes until it became clear and viscous. Finally 15 ml of
Neutralisation Solution (1.32 M Potassium Acetate (pH 4.8)) was added, the
centrifuge tubes inverted several times to mix the solutions, and centrifuged
again at 14 000 x g for 15 minutes at 22-25 °C.
The cleared supernatant was filtered through Whatman filter paper into a
measuring cylinder to determine the supernatant volume. Room temperature
isopropanol (0.5 vol.) was added to the supernatant, the tubes once again
inverted several times to mix the contents. The solution was again centrifuged
at 14000 x g for 15 minutes at 22-25 °C. The supernatant was discarded and
the pellet resuspended in 2 ml TE buffer (10 mM Tris-HCI (pH 7.5), 1 mM
EDTA). 10 ml of DNA Purification Resin was added to the DNA solution and
the mixture transferred to a Wizard Maxicolumn coupled to a vacuum source.
A vacuum was applied and the solution was pulled through the column. After
this step the column was washed with 25 ml Column Wash Solution (80 mM
PotassiumAcetate, 8.3 mM Tris-HCI (pH 7.5), 40 JlMEDTA) and rinsed with
5 ml of 80% (v/v) ethanol.~The vacuum was applied for an additional minute
to allow the column to dry.
The maxicolumn was inserted into a 50 ml screw-cap centrifuge tube and
centrifuged in a swinging bucket rotor at 1300 x g (2500 rpm) for 5 minutes at
room temperature. The column was dried for 5 minutes by re-applying the
vacuum and then placed in a provided 50 ml screw-cap centrifuge tube. 1.5
ml of preheated (650 C) water (or TE buffer [115]) was added to the
maxicolumn. After 1 minute the plasmid DNA was eluted into the tube by
centrifuging at 1 000 x g for 5 minutes. The concentration of the DNA was
calculated by measuring the 00 (optical density) on a spectrophotometer at
260 nm, using the fact that 50 Jlg of pure DNA would give a reading of 1 at
260 nm. The purity of the DNA was also assessed by determining the ratio of
absorbance at 260 nm over the absorbance at 280 nm. The ideal should be
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1.8 and if it is lower it means that there is protein contamination. Plasmid
preparations were subjected to restriction enzyme digestion (see section 5) to
linearise the plasmid. This linear and an uncut sample was run on an
analytical agarose gel (see section 6) to confirm the sizes of the plasmids and
whether the plasmid was in the supercoiled conformation.
4.2 Extraction of plasmid DNA by the Wizard Midiprep DNA Purification
System
The protocol used was in accordance with the manufacturer (Promega). The
isolation of plasmid DNA from bacterial cells using the Wizard Midiprep DNA
Purification System was in essence performed in the same way as the
Maxiprep method described in section 4.1. The volumes of the starter
cultures ranged from 10-100 ml and the reagent volumes were also in the
range of 3 ml instead of the 15 ml used in section 4.1. The volumes were thus
smaller and centrifugation steps could be performed on a bench top
centrifuge.
5. Restriction enzyme digestion of DNA
Restriction enzyme digestion of DNA was performed with various restriction
endonucleases in the presence of their appropriate buffer, supplied by the
manufacturer (Boehringer Mannheim, Roche). As the restriction enzymes are
supplied in a glycerol solution, the volume of enzyme added never exceeded
one-tenth of the final volume. Digest samples were incubated for 1-2 hours or
overnight at 37°C, unless a different optimum temperature was indicated.
Double digests i.e. digestions with two enzymes at the same time, were
performed simultaneously if their optimum temperatures and buffer conditions
were compatible; otherwise the DNA was first digested with one enzyme,
ethanol precipitated, and then digested with the other enzyme. Volumes
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varied according to the amounts of DNA that were digested, but normally 5
units of enzyme was added to every 1 Jlg of supercoiled DNA. Digestion
reactions were terminated by adding an equal volume of 2x concentrated gel
loading buffer (see section 6) and analysed on an analytical agarose
electrophoresis gel (see below).
6. Analytical Agarose gel electrophoresis of DNA
0.75 or 1% (w/v) Agarose gels, depending on the size of the fragments
involved, were used to determine the sizes of bands after restriction enzyme
digestion and as preparative gels to isolate DNA fragments for cloning (see
section 12). Preparative and analytical agarose gel electrophoresis of DNA
fragments was performed according to the protocols of Sambrook, J. et al.
(1989) [115].
Agarose powder (Sigma) was weighed in a 250 ml Erlenmeyer flask. The
agarose was dissolved in 1 X TAE (40 mM Tris, 30 mM Acetate, 2 mM EDTA
(pH 8)) or 1 X TBE buffer (89 mM Tris; 89 mM Borate, 2 mM EDTA (pH 8)).
The opening of the flask was covered with plastic wrapping and a few holes
punched in the plastic with a needle or other sharp instrument. It was placed
into a microwave oven and heated. The flask was swirled around to check
that all the agarose was in solution after which ethidium bromide (10 mg/ml)
was added to a final concentration of 0.5 Jlg/ml to enable the visualisation of
the DNA fragments under ultraviolet light. Special care was taken when
handling ethidium bromide as it is a suspected carcinogen.
The gel solution was allowed to cool down to about 50 oe and was then
poured very carefully, to avoid forming bubbles, into a horizontal gel moulding
chamber with a suitable comb in it. The gel was allowed to set for about 30
minutes, the comb was removed and the gel chamber was transferred to a
horizontal electrophoresis chamber and covered with 1 x TBE or 1 x TAE
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running buffer. DNA samples in 1 x loading buffer (0.04 % (w/v) bromophenol
blue, 0.04 % (w/v) xylene cyanol, 5 % (v/v) glycerol in water) were loaded into
the wells with a pipette, and the gel was allowed to run for about 90 min at 60
- 100 V (less than 10 V/cm of gel); until the bromophenol blue in the loading
dye had travelled about% of the length of the gel. The gel was then taken out
and, in a darkened room, put on a UV lightbox and photographed. The bright
bands on the photo was caused by ethidium bromide (EtBr) intercalating with
DNA and absorbing UV radiation. The markers that were used were pBR322
digested with Hpa /I which gave sizes of 622 bp; 527 bp; 404 bp and 300 bp;
as well as A (23 kb) digested with Pst l, which gave a ladder of bands namely
14 kb; 11 kb; 5,1 kb; 4,8 kb; 4,5 kb; 2,6 kb; 2,0 kb; 1,7 kb; 1,2 and 1,1 kb;
800 bp and 500 bp.
7. Separation of DNA fragments by low melting preparative agarose
electrophoresis
Lowmelting agarose preparative electrophoresis was carried out according to
the manufacturer's (FMC Bio Products) protocols. Seaplaque agarose was
used for separation of DNA fragments of 1000 bp or more and Nusieve
agarose for DNA fragments smaller than 1000 kb. Methodologically the
preparation and execution of preparative electrophoresis was very similar to
analytical gel electrophoresis (see above). Differences included the
additional step of putting the setting gel at 4 °C for 30 minutes to promote the
setting of the gels. The gels were also electrophoresed at lower voltage of
about 5 V/cm of gel in 1 x TAE running buffer. After electrophoresis the gel
was taken out and examined with a long wavelength ultraviolet light and the
bands of interest cut out with sterile scalpel blades.
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8. Purification of DNAfragments from low melting agarose gels
8.1 Wizard peR Preps DNAPurification System
The protocol of the manufacturer (Promega) was followed. The agarose gel
slices containing the DNA fragments of interest were placed in sterile 1.5 ml
microcentrifuge tubes and incubated at 70 oe until the gel had melted. 1 ml
Resin was added to the melted agarose and carefully mixed, but not
vortexed. A Wizard Minicolumn was attached to a syringe barrel and coupled
to a vacuum source. The DNA/Resin mixture was pipetted into the syringe
barrel and a vacuum applied to draw it into the column. The vacuum was
broken and 2 ml 80% (v/v) isopropanol was added to the syringe and the
vacuum reapplied. After the solutions were drawn through the column the
vacuum was applied for an extra 30 seconds to dry the column. The syringe
barrel was removed and the column transferred to a 1.5 ml microcentrifuge
tube and spun for 2 minutes at 10 000 x g. The column was transferred to a
new microfuge tube and 50 !lI of H20 added. In the case of a small fragment
or insert the water was added at room temperature, but for big fragments or
plasm ids the water was heated to 65 oe. After a one minute wait period the
DNA fragments were eluted by spinning the column for 20 seconds at 10 000
x g at room temperature. The DNA solution was stored at -20 oe until later
use.
8.2 NucleoSpin Extract 2 in 1 Kit
All steps were performed in accordance with the protocol supplied by the
manufacturer (Macherey-Nagel). The components of the various buffers used
were not disclosed in the packet information booklet. The DNA fragment was
excised from the gel with a sterile scalpel blade and the weight determined
before it was transferred to a microfuge tube. For each 100 mg of gel, 300 !lI
of buffer NT1 was added and the tube incubated at 50 oe for ten minutes with
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occasional vortexing. The sample was then loaded onto a NucleoSpin tube
and placed in a 2 ml centrifuge tube. The samples were centrifuged for 60
seconds at 6000 x g at room temperature, and the resultant flow-through
discarded. The NucleoSpin tube was once again placed into the centrifuge
tube and 700 JlI of buffer NT3 was added, followed by a 60 second spin at
maximum speed. The previous steps were repeated and the flow-through
discarded in each case. The NucleoSpin tube was centrifuged once again to
remove all of the buffer NT3. The NucleoSpin tube was placed into a clean
1.5 ml microfuge tube and 50 JlI of elution buffer NE was added, after which it
was once again centrifuged for 60 seconds at maximum speed. The purified
DNA fragments were contained in the flow-through and were stored at -20 °C
until further use.
9. Mutagenesis
Prior to the start of this study the SF-1-like site 1 of the GnRH receptor gene
promoter, situated at -12 relative to the ATG start codon, had already been
mutated and inserted intca luciferase reporter vector by Carmen Pheiffer
[58]. There thus existed two different constructs: a wildtype GnRH-R promoter
reporter construct named LG and a GnRH-R promoter with mutated SF-1-like
site 1 named LGM1. A strategy was devised to mutate the second SF-1-like
site (at -247 relative to the ATG) of both these constructs which would result
in the generation of four different constructs, as shown in figure 3.3, i.e. the
two mentioned above as well as a construct with just SF-1-like site 2 mutated
named LGM2 and another construct where both SF-1-like sites 1 and 2 were
mutated, named LGM1/2.
A Polymerase Chain Reaction (PCR) strategy was developed to mutate the
second SF-1-like site by using specially designed mutation primers that would
transform the second SF-1-like site into a restriction site for the enzyme Pst I.
Thus by digestion with this enzyme the success of the mutagenesis could
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easily be determined. Firstly the wildtype construct (LG) was subjected to
PCR up with the primers GL1 (situated in the polylinker of the pGL2-basic
plasmid) and the antisense mutation primer 116. In a separate reaction the
wildtype construct was subjected to PCR with primers GL2 and the sense
mutation primer 115. The "Expand High Fidelity PCR System" from Roche
was used. Reactions were performed in a final volume of 50 !l' in the
presence of 0.2 mM dNTPs, 2 ng wildtype (LG) plasmid, 1 x Expand buffer
already containing MgCb and 0.75 ul Expand Enzyme Mix (making the final
concentration of the enzyme mix 1.5 x). Primers, either GL1 and 116 or GL2
and 115 were added at a final concentration of 0.4 !lM. The mixture was spun
down and the PCR cycle was as follows: 2 minutes at 94 DC,followed by ten
cycles of 15 seconds at 94 DC,30 seconds at 55 DCand 45 seconds at 72 DC.
The next twenty cycles consisted of 15 seconds at 94 DC,30 seconds at 55
DCand 1 minute at 72 DC.The last incubation period was 7 minutes at 72 DC.
The PCR was performed in aStratagene RoboCycler. Two products were
formed, the product from GL1 to 116 was 412 bp long and another product of
297 bp was formed from 115 to GL2. These DNA fragments were gel purified
in low melting preparative agarase and then purified with the Promega
Wizard PCR Preps DNA purification system. The next step was the fusion of
the GL1/116 and GL2/115 products. The areas around the 116 and 115
primers were complementary to each other and would thus act as primers for
the fusion reaction. Two different amounts of templates were used i.e. 300 ng
or 50 ng. Templates were mixed with a final volume of 30 ul in the presence
of 0.2 mM dNTPs, 1 x Expand buffer with MgCI2 and 1.5 x Expand Enzyme
mix. After mixing and spinning down the reactions were subjected to PCR for
thirty cycles as follows: 30 seconds at 94 DCfollowed by 30 minutes at 72 DC.
The product was examined on an agarase gel and found to be too little for
further cloning experiments. The PCR product was therefore reamplified with
the GL1/GL2 primers by adding 10 ul of the PCR product so that the final
reaction volume was 50 ul. The reaction was performed in the presence of
0.2 mM dNTPs, 1 x Expand buffer with MgCb, 1.5 x Expand Enzyme mix, and
0.4 !lM each of the primers GL1 and GL2 using the same cycle program as
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above. After checking the product on an analytical agarose gel, the rest of the
product was purified on a low melting agarose gel and Wizard PCR Preps
DNA purification system. It was then ethanol precipitated by adding 1/10
volume (v/v) ammonium acetate and 21/2 volume (v/v) ethanol and keeping it
at -20°C overnight. The DNA was then centrifuged for 30 minutes at 20000 x
gat 4°C, followed by a 70 % ethanol wash and finally dissolved in 8 JlI H20.
The next steps involved the restriction digestion of the PCR product as well
as the reporter vector and the subsequent gel purification, ligation of the PCR
product and the reporter plasmid (section 10) and transformation of the
ligated construct into bacterial cells (section 12) and the screening of
colonies (section 13) to ascertain whether the colonies did in fact contain the
newly made mutated construct i.e. LGM2. The DNA was also sent for
sequencing to the DNA sequencing facility at the University of Stellenbosch.
The whole procedure was then repeated with the other LGM1 GnRH-R
construct to yield LGM1/2 (see figure 3.3.).
10. Ligation
The ligation reaction was done with reagents and solutions from the pMOS kit
(Roche). A molar ratio of 5:1, insert to vector was used. 49 ng of insert
(mutated GnRH-R promoter region) was ligated into 90 ng of vector (pGL2-
basic luciferase reporter plasmid) in a final reaction volume of 7 JlI, in the
presence of 1 x T4 ligase buffer (Roche), 8 mM OTT, 10 mM ATP, 0.5 JlI T4
DNA ligase (Roche) and 4.5 JlI H20. The mixture was incubated overnight at
16°C in the Stratagene RoboCycler.
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11. Making electrocompetent cells
DH5a (a kind gift from A. Swart, Department of Biochemistry, University of
Stellenbosch) and JM109 (Promega) Escherichia coli cells were plated out on
Luria broth (LB, see appendix A) agar plates and grown overnight at 37°C.
Starter culture flasks with 50 ml SOB (appendix A) were inoculated with
above mentioned bacteria and incubated in a shaking incubator overnight at
37 °C. The next day a flask with 500 ml of SOC (Appendix A) medium was
inoculated from these starter cultures and incubated for 2-3 hours at 37°C
with constant agitation until the optical density at 550 nm was 0.8 units. The
culture flask was put on ice to cool down and all subsequent steps were
performed on ice to ensure the highest possible transformation efficiency.
The cells in the culture flask were transferred to a centrifuge bottle and
pelleted by centrifugation at 2 500 x g at 4 °C for 15 minutes. After discarding
the supernatant the pelleted cells were resuspended in 200 ml ice-cold sterile
distilled H20. After a repetition of the preceding washing steps the cells were
washed in ice-cold sterile 10 % (v/v) glycerol. The cells were resuspended in
ice-cold sterile 10 % (v/v) glycerol so that the optical density at 550 nm was
100 to 300 units. The electrocompetent cells were aliquoted into prechilled
microfuge tubes and snap frozen on dry ice before storage at -80°C.
12. Transformation of electrocompetent cells
Electrocompetent DH5a or JM109 E. coli cells were transformed by
electroporation using the Savant GTF 100 Gene Transformer.
Electrocompetent cells were carefully removed from storage at -80°C and
thawed on ice. All cuvettes and microfuge tubes were also chilled on ice. 100
ng of DNA in a total volume of 2.6 jll was added to 40 jll electrocompetent
cells and gently mixed. The cell/DNA mixture was quickly pipetted into a
chilled electroporation cuvette, the lid closed, and transferred to the slot in
the electroporator. Care was taken to remove all bubbles in the solution as
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this would cause arcing and incomplete transformation. A pulse of 1800 V
was passed through the solution. The sample was quickly removed and 1 ml
of room temperature SOC medium (see appendix A) added, followed by an
incubation period of 1 hour at 37°C with shaking. After incubation 50 III of the
sample was plated out onto LB-agar plates with the appropriate antibiotics.
The rest of the solution was spun down, the supernatant removed, and
resuspended in 50 III SOC medium. This was also plated out onto LB-agar
plates and the plates were placed at 37°C overnight so that transformed
colonies could grow. Transfectional efficiency was calculated at 2.6 x 106
cfu/Ilg DNA.
13. Screening of colonies
It was important to screen the colonies formed on the LB-agar plates after
transformation to certify that the colonies contained the insert and were not
the result of self-ligated vector. This was done by a PCR screening method
using the GL1 and GL2 primers situated in the polylinker. From the size of the
PCR product it would be possible to determine whether the correct insert was
present. Colonies were picked off the LB-agar plates with sterile toothpicks
and used to inoculate 20 III sterile H20. 5 III of this bacterial suspension was
added to make a final reaction volume of 20 Ill, containing 0.25 mM dNTPs, 1
x PCR buffer (Promega), 1 IlM each of GL 1 and GL2, 1.5 mM MgCI2 and 0.5
III Taq Polymerase (Promega). The mixture was mixed well and 50 JlI of
mineral oil added. The PCR cycle was as follows: 35 cycles of: 1 minute at 94
°c, 1 minute at 50°C and 1 minute at 72 °C. The final incubation step was 10
minutes at 72°C. The products were seperated by agarose gel
electrophoresis. The rest of the bacterial suspension was used to make
glycerol stocks: 400 III LB medium with ampicillin added at 50 Ilg/ml, were
incubated by the samples and incubated overnight at 37°C. The next
morning 400 III of 80% (v/v) glycerol was added and the stocks stored at -80
°C.
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14. Radioactive labelling of DNA
14.1 Labelling using the Megaprime™ DNA labelling system
The Megaprime™DNA labelling system (Amersham) uses random sequence
hexanucleotide primers to attach to numerous sites along the length of a
denatured template DNA. This primer-template complex is a target for the
Klenow fragment of DNA polymerase I. New DNA is synthesised in the
presence of a radiolabelled nucleotide. [a-32P]-dCTP nucleondes were used
in labelling reactions and all necessary safety precautions [116, 117] were
followed. Laboratory coats and gloves were worn at all times when handling
the radioactive material. A Geiger counter was strategically positioned to
monitor any spills during the experimental procedure. All work was done
behind a perspex screen and the area and person was regularly monitored
for contamination.
DNA fragments to be labelled were treated by restriction enzyme digestion
and separation from their vectors by preparative agarase gel electrophoresis
(see sections 5 & 7), followed by purification from the gel (section 8). The
GnRH-R cDNA was excised by restriction digestion with EcoRI and Xhol
resulting in a fragment of 1.2 kb. The J3-actinplasmid was digested with
BamHI and the cDNA insert was 1.9 kb in size. The Megaprime™ labelling
protocol of the manufacturer (Amersham) was followed. 25 ng of DNA and 5
!lI of Primer Solution was made up to a volume of 33 ul with H20 and
denatured for 5 minutes at 95-100 °C boiling waterbath. The sample was then
spun down and 1 x Labelling Buffer (dATP, dGTP, dITP in Tris-HCI (pH 7.5),
2-mercaptoethanol and MgCb, concentrations not given), 5 ul [a-32P]-dCTP
(3000 Ci/mmol, Amersham) and 2!l1 DNA Polymerase Klenow enzyme (1
unit/nl) were added. The sample was mixed and once again spun down
followed by an incubation of an hour at 37°C. The reaction was stopped by
the addition of 5 !lI 0.2 M EDTA and the volume made up to 100 !lI with TE
buffer [115]. After purification to remove all unincorporated nucleotides (see
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below) the labelling efficiency and specific activity of the probes were
determined by Cherenkov counts obtained in a Beckman Scintillation
Counter. The specific activity was usually in the region of 108 to 109 dpm/~g
(disintegrations per minute per microgram DNA labelled).
14.2 Removal of unincorporated radioactive nucleotides
It is important to remove all the unincorporated radioactive nucleotides from
the probes to accurately determine the specific activity of the probes. The
methodology was adapted from Sambrook, J. et al. (1987) [115]. The
unincorporated radioactive nucleotides were removed by using Sephadex
spin columns. Autoclaved glasswool was used to plug the tip of a sterile 1 ml
syringe. Sephadex (G25 or GSa, Sigma) was added and allowed to settle
until the syringe was filled. 100 ~I of TE buffer was pipetted on top of the
column and the column was spun for 1 minute approximately 400 x g on a
bench top centrifuge. This wash process was repeated 4 times. The syringe
was placed in a new centrifuge tube with a microfuge tube at the bottom to
recover the sample. The radiolabelled DNA solution was then added on top of
the column and centrifuged for the same time and speed. The purified
radiolabelled DNA probe had collected in the microfuge tube and was
transferred to a fresh tube, whilst the unincorporated nucleotides were
trapped in the Sephadex spin column.
15. RNAisolation
RNA was isolated by the Tri-Reagent method described by Chomczynski, P.
(1993) [118]. TRlzolTM Reagent (GIBCD BRULife Technologies) or TRI
Reagent™ (Molecular Research Centre) were used and the protocol from the
manufacturers was followed. All work was done in RNase free conditions in a
laminar flow hood and with pipettes and equipment used solely for RNA work.
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All glassware was baked overnight at 180 °C and most solutions made up
with diethyl pyrocarbonate (DEPC 111llml) treated water [115]. Plastic
apparatus was soaked in a 3% (v/v) H202 solution and rinsed with RNase-free
water. Pipettes were also equipped with filter tips to prevent any RNase
contamination. Gloves were also worn at all times and changed regularly.
RNA was isolated from tissue culture cells grown in a monolayer in 10 ern'
dishes. These monolayer cells were directly lysed in the culture dish, without
any washing steps. TRlzol or TRI Reagent was added in the following
manner: 1 ml per 10 cm2 was pipetted onto the monolayer of cells and the
dish rotated to ensure complete coverage of the cells. The cell lysate was
sucked up and down through a pipette several times until most of the clumps
had disappeared and were then transferred to microfuge tubes. The samples
were incubated at room temperature for 5 minutes after which 200 III
chloroform was added in a fumehood and the tube vigorously mixed for 15
seconds. Another room temperature incubation step of 2 to 15 minutes
followed (the maximum time indicated was always followed) and then the
samples were centrifuged for 15 minutes at 12 000 x g at 4°C. The aqueous
phase containing the RNA yvastransferred to a new microcentrifuge tube and
500 III of 100% (v/v) isopropanol was added, and mixed thoroughly. Once
again the tubes were incubated for 5 - 10 minutes at room temperature
followed by centrifugation at 12 000 x g for 10 minutes at 4 °C. The
supernatant was discarded and the gel-like pellet containing the RNA was
washed with 1 ml 70% (v/v) ethanol and centrifuged for 5 minutes at 7500 x g
at 4 - 250 C. The pellet was air dried at room temperature and dissolved in
50 III FORMAzol™(Molecular Research Centre). The concentrations of the
RNA samples were calculated by using 00 (optical density) readings at 260
nm and using the fact that 40 llg of pure RNA gives an 00 reading of 1 at
260 nm. By comparing the ratio of 00 at 260 nm relative to the 00 at 280 nm
the relative purity could be estimated.
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16. RNA gel electrophoresis
Analytical and preparative RNA gel electrophoresis was performed in 1%
(w/v) agarose gels containing 0.66 M formaldehyde. This protocol was
adapted from Sambrook, J. et al. (1987) [115] and Ausubel, F.M. et al. (1987)
[116]. The gel chamber and combs were soaked in 3% (v/v) H202 solution for
an hour before the gel was poured followed by a wash with DEPC-treated
water. 1 gAgarose was added to 1 x MOPS buffer (0.1 M MOPS, (pH 7.0), 40
mM sodium acetate,S mM EDTA (pH 8)) and 86 ml water. The mixture was
boiled in the microwave oven until a" the agarose had been dissolved. The
gel solution was allowed to cool down to about 50°C before adding 5.3 ml
formaldehyde, making the final concentration of formaldehyde in the gel 0.66
M. The gel was allowed to set for about 60 minutes and then transferred to a
gel chamber filled with 1 x MOPS buffer. The buffer volume was just enough
to cover the gel by about 2-3 mm.
The RNA samples in FORMAzol were thawed and placed at 55°C for 10
minutes to ensure complete solubilisation of the RNA. A stock of gel loading
cocktail was made containing: 63 III DEPC-H20, 81 III formaldehyde, 48 III of
bromophenol blue (25 mg/ml) in 50 % (v/v) glycerol and 48 III 10 x MOPS
[44]. For analytical RNA gels 5-10 Ilg of sample was loaded, but for
preparative i.e. gels used for northern blotting, 20 Ilg of sample was loaded.
An equal volume of RNA sample and gel loading cocktail was added and
incubated at 55°C for 15 minutes. In the case of analytical gels 0.5 III of
ethidium bromide (10 mg/ml) was also added to the samples. After the
incubation the samples were loaded onto the gel and run for 2 to 21/2 hours at
60-70 V. In the case of analytical gels the RNA bands were visualised under
ultraviolet light.
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17. Northern blotting procedure
The procedures followed were modified from those described by Sambrook,
J. efal. (1987) [115].
17.1 Mono-directional transfer of RNA
This procedure is also known as a capillary blot because it uses capillary
forces to transfer RNA from a gel onto a nylon membrane. A rectangular
glass dish was filled with 20 x SSC (3 M NaCI, 0.3 M sodium citrate, pH 7.0).
A glass plate was placed on top of the dish to create a platform or bridge. A
wick made from three sheets of Whatman 3MM paper was put over the bridge
so that the ends were still hanging into the SSC solution. Care was taken to
remove all possible air bubbles by ironing the wick with a sterile rod. The
formaldehyde gel (see above) was washed with 2 x SSC and placed on the
wick, again making sure that no air bubbles were trapped beneath it. The
whole apparatus was covered with cling wrap to prevent the blotting buffer
from being absorbed from anywhere but through the gel. The cling wrap
covering the gel was cut a"'(aywith a sterile scalpel.
A sheet of Hybond-N' membrane (Amersham)was cut to the exact size of the
gel and soaked for 5 minutes in 2 x SSC, before it was placed onto the gel.
Air bubbles were squeezed out with a sterile rod. On top of the membrane
three pieces of Whatman 3MM filter paper were placed, after they too had
been wet in 2 x SSC. A stack of folded absorbent towels about 5 cm high was
placed on top of this and lastly another glass plate was put on top followed by
a weight of about 0.5 kg. The apparatus was allowed to transfer overnight.
The next morning the apparatus was carefully dismantled and the positions of
the wells marked on the membrane with a pencil before it was removed. The
membranewas washed briefly in 2 X SSC to remove any agarose and placed
on filter paper to air dry for 30 minutes. The membranewas then placed RNA
side up into a UV crosslinker (Amersham) and exposed for 12 seconds at 312
Stellenbosch University http://scholar.sun.ac.za
59
nm wavelength to fix the RNA onto the membrane. The membrane was then
subjected to the hybridisation step immediately or could be wrapped in cling
wrap and stored at 4 oe until hybridisation.
17.2 Hybridisation
Hybridisation procedures were carried out with DIG-Easy Hyb solution
(Boehringer Mannheim, Roche) and the protocols of the manufacturer were
followed. An appropriate amount (20 ml/100 ern" of membrane) of
hybridisation solution was prewarmed at the optimum hybridisation
temperature (50 oe in this case). The membrane was incubated in the pre-
Hyb solution for at least 30 minutes with gentle agitation in a hybridisation
oven at 50 oe. Meanwhile the 32p radiolabelled DNA probe was denatured by
boiling or heating at 95 oe for 10 minutes followed by a rapid cooling on iee.
The denatured probe was added to the hybridisation solution (at least 10
ml/100 ern") and mixed. As the specific activity of the probes ranged from 108
to 109 dpm/Jlg for 100 Ill, the final concentration in 50 ml of hybridisation
solution was in the region Qf 105 to 106 dpm/Ilg. The pre-Hyb solution was
poured off and kept for later reuse and the probe/DIG-Easy Hyb solution was
added to the membrane. This was incubated overnight at 50 oe with gentle
agitation.
The next morning the Hyb solution was removed and a series of washing
steps took place. The membrane was first washed twice for 5 minutes in
ample 2 x sse; 0.1 % (v/v) sos at room temperature. Then the membrane
was washed twice for 15 minutes in ample 0.1 x sse; 0.1 % (v/v) sos at 50
oe with gentle agitation. After each washing step the membrane was checked
with a Geiger counter to establish how "hot" the membrane still was. After the
last wash the excess fluid was blotted off and the membrane wrapped in cling
wrap, ready for detection by autoradiography. When necessary the
autoradiograph was stripped, i.e. the radioactive probe was removed, as
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follows: The membrane was removed from the clingwrap and placed in a
plastic dish. A solution of boiling 1% (w/v) SOS was poured over the
membrane and it was agitated on a rotary shaker for 2 - 4 hours to strip off all
the radioactive probe. It was then taken from the stripping solution and put
into a pre-hyb solution to commence reprobing.
18. Autoradiography
Membraneswere probed with [a-32P]-dCTP labelled DNA probes (see above)
and exposed to HYPERfilm™(Amersham) in a lightproof exposure cassette at
-70°C, with an intensifying screen, for time periods ranging from 1 hour to 1
week, depending on the specific activity and age of the probe. The cassette
was taken out of the -70°C freezer and allowed to thaw to room temperature.
In a dark room with only red-light illumination, the film was taken out and
placed in developing solution (Cronex, Protea Medical Services) for
approximately 2 minutes. The film was removed with plastic tweezers and
rinsed under running tap water until all the developer had been washed off.
The film was then placed into a fixing solution (Cronex, Protea Medical
Services) for another 2 minutes, followed by another rinse, after which the
film was hung up to air dry. To quantify the radiolabelled probe signals on
these films, the films were scanned using a densitometer (Shimadzu, Dr.
Gene Roussou, University of Cape Town) and relative values were given
based on the intensity of the various bands. These values were then used to
construct diagrammatic histograms (see results), using the Graphpad Prism
computer program.
19. Tissue culture
Immortalised aT3 cells from mouse pituitary gonadatrapes [24], a kind gift
from Pamela Mellon, Regulatory Biology Laboratory, The Salk Institute, La
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Jolla, California, were used in all experiments. The aT3 cells were
maintained in Dulbecco's Modified Eagle Medium (DMEM, Gibco BRL)
supplemented with 1 gIL glucose. The DMEM was also supplemented with
10% (v/v) fetal calf serum (FCS, Highveld Biological) and 1U/ml Penicillin-
Streptomycin (Gibco BRL, 100U/ml). The fetal calf serum was heat
inactivated before use by heating it to 50°C before freezing it at -20°C. Cells
were grown in sterile polystyrene 75 cm2 culture flasks (Pyrex, Falcon or
Corning) or 100 mmdishes (Corning) with 10-12 ml of medium and incubated
at 37°C with 5% CO2. The medium was removed every 4-5 days and
replaced with fresh media in a sterile hood using sterile pipettes.
When cells became confluent, they were passaged by removing the medium
and adding 3-5 ml of a trypsin solution (see appendix A) to the flask. The
flask was then replaced into the incubator and left for an additional 5 - 10
minutes. After this incubation time, most of the cells were no longer attached
to the flaskbed and floating in the liquid. Some cells were still attached to the
bottom and were removed by gently tapping on the side of the flask with one
hand. By using an automatic pipette the liquid was sucked up and down to
wash off any cells still clin~ing to the flask; as well as breaking up any cell
clumps. For routine culture splitting, the trypsin solution containing the cells
was then transferred into a 50 ml screw-cap centrifuge tube and mixed with
about 40 ml of medium. This solution was then added to 4 or 5 new flasks
and split 1:4 or 1:5, depending on the confluence and growth rate of the cells,
and returned to the incubator. If new flasks were not needed the rest of the
cells were discarded or used to make stocks.
For cell counting, and subsequent plating out into multiweIl plates or Petri
dishes, ± 35 ml of fresh medium was added to the trypsin solution in the
centrifuge tube so that the final volume was 40 ml. The cells were spun down
at 200-500 rpm in a bench top centrifuge with a swinging bucket rotor for 5
minutes. The supernatant was aspirated and the cell pellet resuspended in a
small amount of medium to ensure that all cell clumps were dispersed. More
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medium was later added (± 50 ml, depending on the confluency of the flask
being counted) and from this suspension 100 JlI was removed and added to
the same amount of trypan blue (10 mg/ml) in a microfuge tube. The tube was
stored on ice for 5 minutes, after which a haemocytometer was loaded by
capillary action. The amount of cells in ten squares of the haemocytometer
(X) was counted, but cells that were stained blue were not counted as they
indicated the dead cells. The concentration of cells were calculated as
X
follows: [Cells I ml] = - x 104 X 2.
10
For RNA isolation studies cells were plated out at densities of 2-2.5 x 106
cells per 100 mm dish and 10 ml medium, with 10% fetal calf serum, was
added. The cells were grown overnight and then test compounds were added
in dimethyl sulfoxide (DMSO), at a final concentration of equal or less that
0.1%, and left on for a specified period after which the RNA was isolated. For
plating into 6-well plates for transfection experiments see section 20.2.
20. Transfections
20.1 Transfection of aT3 cells with the calcium phosphate method
The calcium phosphate transfection method was adapted from Ausubel, F.M.
et al. (1987) [116] and Ferguson, C. (personal communication). Cells were
plated out at 5 x 104 cells per well into 6-well tissue culture plates (Falcon or
Nunc). Fresh medium, with 10% fetal calf serum (FCS), was added, 2.5 ml
per well, and the cells were allowed to settle overnight. The following day the
transfection mix was made containing 12 Jlg of GnRH-R reporter construct
and 2.75 Jlg f3-galactosidase expression vector as control for transfectional
efficiency, per well. Since the transfections were performed in duplicate the
mix for two wells was combined and thus contained 24 Jlg GnRH-R reporter
construct and 5.5 Jlg f3-galactosidase expression vector. This was added to
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20.8 III 2 M CaCb and the volume was made up to 170 III with water, and this
tube was labelled A. In a separate tube, designated B, 1.7 III phosphate
buffer (P04 Buffer) (70 mM Na2HP04, 70 mM NaH2P04, pH 7.0) was added to
170 III 2 x HeBS (HEPES buffered saline, see appendix A). The contents of
tube A was added dropwise to tube B, followed by vortexing after each drop
and left to incubate at room temperature for 30 minutes until a fine precipitate
formed. The precipitate was resuspended and added to the cells in a
dropwise manner. The precipitate was left on the cells for 24 hours and then
they were twice washed with phosphate buffered saline (PBS) (10 mM
Na2HP04, 1.75 mM KH2P04, 137 mM NaCI, 2.7 mM KCI, pH 7.0)
20.2 Incubation with test compounds
As seen above, after the transfection procedure the cells were washed twice
with phosphate buffered saline (PBS) and then fresh medium containing 10%
fetal calf serum (FCS), was added. The test compounds were then added and
the cells incubated with the test compounds for a specified amount of time.
Forskolin (Sigma) and B-Bromo-cyclic AMP (Sigma) were added in dimethyl
sulfoxide (DMSO) and 25-hydroxycholesterol (Sigma) was added in ethanol
to the cells. The final concentration of ethanol or DMSO was equal or less
than 0.1 %.
20.3 Preparationof cell extracts
After the incubation period with the test compounds was over the cells were
ready for preparation of cell extracts. This was done according to the
procedures in Promega's 'Luciferase Assay Kit'. The Reporter Lysis Buffer
(RLB) supplied with the kit was diluted 4 x with H20 to make a 1 x RLB
solution. Meanwhile the medium was removed from the cells and they were
washed twice with PBS before 250 III of 1 x RLB was added to each well. The
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plates were rotated to ensure complete coverage of the cells and left at room
temperature for 15 minutes. Cells were then scraped with a rubber policeman
or cellscraper and the lysate transferred to a microfuge tube and placed on
ice. The tubes were then vortexed and centrifuged for 30 seconds at 12000 x
g at room temperature. The supernatant was then transferred to a new tube
and allowed to freeze at -80°C before the assays were done.
20.4 Luciferaseassays
Manual luciferase assays were adapted, according to C. Ferguson, from the
Promega Luciferase kit manual [58]. 350 !lI Tris-acetate buffer (0.1 M Tris-
acetate, 2 mM EDTA, pH 7.75 with acetic acid) and 100 ul luciferase assay
substrate were added to a cuvette and vortexed before being inserted into a
luminometer (1253-003 Luminometer, BioOrbit) and the background reading
taken. The adaptation from the kit manual, in regard to the addition of Tris-
acetate buffer, was done to ensure an adequate volume in the cuvette. The
cuvette was quickly removed and 20 ul of cell extract added, once again
vortexed and the luminescence read after 30 seconds. The luciferase values
were divided by the {3-Galactosidase values (see below) to correct for
transfectional error and expressed relative to a control value.
Promega luciferase assays were also done with the automatic Luminoskan
RS (Labsystems). In this case only 10 ul of cell extract was pipetted into
black 96-well plates (Nunc). The plate was inserted into the Luminoskan,
which automatically dispensed 50 ul of luciferase substrate into each well,
immediately followed by the reading of the luminescence value. Due to the
small area of the wells in the 96-well plate, the addition of Tris-acetate buffer
was not necessary.
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20.5 J3-Galactosidaseassays
20.5.1 Spectrophotometric J3-Galactosidaseassay
Manual J3-Galactosidaseor J3-Galassays were performed by adding 30 ~I of
Buffer Z (60 mM Na2HP04, 40 mM NaH2P04.2H20, 10 mM KCI, 1 mM MgCb,
50 mM J3-mercaptoethanol,pH 7.) to 10 ~I cell extract in a microfuge tube
[58]. To start the reaction 8 ~I of 4 mg/ml of the J3-Galsubstrate ONPG (0-
nitrophenyl-J3-D-galactopyranoside(Sigma) dissolved in a solution of 60 mM
Na2HP04, 40 mM NaH2P04, pH 7.0) was added and the samples were
incubated at 30°C for 30 minutes or until a yellow colour developed. The
reaction was halted by the addition of 20 ~I 1 M Na2C03 and the samples
spectrophotometrically measured at a wavelength of 420 nm.
20.5.2 Galacto-Star™ chemiluminescent J3-Galactosidaseassay.
The protocol of the manufacturer (TROPIX) was followed. The required
amount (100 ~I per sample) of Reaction Buffer Diluent (100 mM sodium
phosphate pH 7.5, 1 mM magnesium chloride, 5 % Sapphire-II™) was
equilibrated to room temperature and used to dilute the Galacto-Star
substrate1:50. 10 ~I of cell extract was aliquoted into wells of a black 96-we"
microplate and the plate inserted into aluminoskan RS (Labsystems)
microplate reader. 100 ~I of diluted Galacto-Star substrate was automatically
dispensed into each sample and the plate incubated for 60 minutes. The
Luminoskan then read each sample for 1 second to determine the amount of
luminescence in each sample.
20.6 Statistical analysis
Luciferase and J3-Galassay results were graphically analysed with GraphPad
PRISM™version 2.1 software from GraphPad Software Incorporation. The
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data was analysed with One-way ANOVA as well as Dunnet's multiple
comparisons test to determine the statistically significance between
experimentaldifferences.
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CHAPTER 3
RESULTS AND DISCUSSION
1. Preparation of GnRHreceptor promoter constructs
Prior to the start of this thesis, GnRH receptor promoter reporter constructs
had previously been prepared by others i.e. the wildtype (LG) and the SF-1-
like site 1 mutant (LGM1) constructs (see methods). During the course of the
present study two additional constructs were prepared by PCR mutagenesis,
where the SF-1-like site 2 of both of the above constructs was mutated to a
Pst! restriction site, yielding LGM2 and LGM1/2. The creation of these novel
Pst! sites, previously absent in the original constructs, made it possible to
determine the success of the PCR mutagenesis by restriction enzyme
digestion (see figure 3.1). This technique was also used to select bacterial
clones containing the correct plasmid insert for growing up for further
sequencing. Figure 3.1 shows such a digestion as well as an alternative
digestion with HindIII which, just like Pstl, would only cut the constructs once,
thereby linearising them.
Lanes 8 to 11 in figure 3.1 panel A contain the undigested GnRH receptor
constructs. All the constructs are the same size, i.e. 6.8 kilobases, yet all of
them have a major band running lower than 4.1 kb. This is known as
supercoiled DNA and because of its tightly wound structure it moves through
the gel faster than a linear strand of the same length. The presence of the
supercoiled DNA also signifies good quality DNA for transfection. The other,
less intense band seen at around 9 kb represents nicked circular plasmids
i.e. plasmids that have been cut on one strand and are partially unwound.
These bands ran even slower than the linear bands in lanes 2 to 5 which ran
at approximately the 6 kb mark.
Stellenbosch University http://scholar.sun.ac.za
68
1 2 3 4 5 6 7 8 9 10 11 1 2 3
14kb
11 kb
5.1 kb
4.5kb
4.1 kb
2.6kb
2.1 kb
2.0kb
1.7 kb
1.2 kb
1.1 kb
A B
Figure 3.1: Restriction enzyme digestion of the four GnRH receptor promoter constructs.
Plasmids were incubated with 5 U of enzyme per !lg of plasmid at 37°e for 1 hour or
overnight and the digestion products were run on a 0.7% agarose gel at 100V for 80-90
minutes. 3 !lg of DNA was loaded for each sample. Panel A: Lane 1 contains a DNA marker
i.e. Ic DNA digested with Pstl. Lanes 2, 3, 4 and 5 contain LG, LGM1, LGM2 and LGM1/2,
respectively, cut with HindIII. Lane 6 contains LGM2 linearised with Psil and lane 7 shows the
result of the same restriction enzyme on LGM1/2. Lanes 8 to 11 contain the undigested
plasmids in the same order as lanes 2 to 5. Panel B: Negative control digestion by Pst! on LG
and PLGM1. Lane 1 is the same DNA size-marker as in panel A lane 1 i.e. Ic DNA digested
with Pstl. Although the gels are not on the same scale the marker sizes correspond. Lane 2
contain LG DNA digested with Pstl and lane 3 the same enzyme digestion of the LGM1
plasmid. The band in lane 3 is less intense than the one in lane 2 due to an error in loading
the gel.
Hindll/ is an enzyme that cuts only once inside the pGLBasic plasmid and not
within the GnRH receptor promoter region. Therefore digestion with this
enzyme will lead to the linearisation of the plasmids and they will then run
according to size, as seen in lanes 2 to 5. In lanes 6 and 7 the newly
constructed LGM2 and LGM1/2 plasmids that have been digested with Pstl
can be seen. It is clear that the bands are exactly the same size as those
digested with Hindll/, thereby suggesting that those constructs now contain a
SF-1-like site 2 that has been mutated to a Pstl site. It was also found that
Pstl was unable to cut the LG and LGM1 constructs. In figure 3.1 panel B it
can clearly be seen that the LG and LGM1 constructs still ran at the same
,position as uncut plasmids after incubation with Pstl, thus showing that the
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-661 TGTATCTTAT GGTACTGTAA CTGAGCTAAC ATAACCCGGG AGGTACCGAG
-661 TGTATCTTAT GGTACTGTAA CTGAGCTAAC ATAACCCGGG AGGTACCGAG
-6ll CTCTTACGCG TGCTAGCTCG AGATCCACTA GTTCTAGAAT AATTGGTATT
-6ll CTCTTACGCG TGCTAGCTCG AGATCCACTA GTTCTAGAAT AATTGGTATT
-561 AGAACAGGCT GCTTAAAACA GTTAAAGTAC TAGCTATAAG TCCGTCGTGT
-561 AGAACAGGCT GCTTAAAACA GTTAAAGTAC TAGCTATAAG TCCGTCGTGT
-511 GACTATTCAG CAAAATGCAT TTGAAAAGCA ATTGTTTTGA GAAGTATGGT
-511 GACTATTCAG CAAAATGCAT TTGAAAAGCA ATTGTTTTGA GAAGTATGGT
-461 CTTCAAACAA CAGATTTTAA ATTGGATCGG GATTTTTAAA TTACTTTTCT
-461 CTTCAAACAA CAGATTTTAA ATTGGATCGG GATTTTTAAA TTACTTTTCT
-411 GTATTTCATT TTGTATCTGT CTAGTCACAA CAGTTTTTAG AAAACCTATT
-411 GTATTTCATT TTGTATCTGT CTAGTCACAA CAGTTTTTAG AAAACCTATT
-361 CATTAAGGCT AATTGGATGA TATTATGAGT CACTTTCGAC ATCAGAATTA
-361 CATTAAGGCT AATTGGATGA TATTATGAGT CACTTTCGAC ATCAGAATTA
-311 GACTCCAAGT GTCCTTCCTC ACCTACGATA AAAAGACGGG CCATCTGCTG
-311 GACTCCAAGT GTCCTTCCTC ACCTACGATA AAAAGACGGG CCATCTGCTG
121
-261 AGGGGCTACG GTTACACT trG GCCTTCA GA GGGCTTGGCA TGTTCTGTTA
-261 AGGGGCTACG GTTACACT ~AGCTTCA GA GGGCTTGGCA TGTTCTGTTA
-211 GCACTCTTTT AGATTATAAA CCGAAAAACA AGTTTACCTT GATCTTTCAC
-211 GCACTCTTTT AGATTATAAA CCGAAAAACA AGTTTACCTT GATCTTTCAC
-161 GTTAAGTCCA GAGTATCTTG GGAAAAATAA ATTAGGCAGA AATGCTAACC
-161 GTTAAGTCCA GAGTATCTTG GGAAAAATAA ATTAGGCAGA AATGCTAACC
-111 TGTGACGTTT CCATCTAAAG GAGGCAGACA TCAACAGCGC TTCGCGTTCA
-lll TGTGACGTTT CCATCTAAAG GAGGCAGACA TCAACAGCGC TTCGCGTTCA
-61 GTTATGATAA AACATCAGAA GTAACAGGGA CTCCACTCTT GAAGCC~GTCI
-61 GTTATGATAA AACATCAGAA GTAACAGGGA CTCCACTCTT GAAGCC GTC
-11 8GAAA TAGATCTAAG
-11 GAAA TAGATCTAAG
69
Figure 3.2: DNA sequencing results of the LGM2 GnRH receptor reporter construct.
compared to the wildtype sequence. The bottom, red sequence represents LGM2 and the
top. blue sequence that of the wildtype LG. The two SF-1-like sites are bold and boxed and
the mutations to site 2 can clearly be seen when comparing the sequences. The site 1
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sequence however is still identical. The areas in black represent sequences from the reporter
plasmid pGL2basic. The area in Italics represents the ATG transcription start site that had
previously been mutated to AGA (bold) (see methods). The numbering is relative to the ATG
start codon. Figure by G. Styger.
result was specific and not merely a non-specific artefact of the digestion.
The restriction digestion evidence was however not enough to prove whether
mutagenesis was successful or not, even with the additional evidence that
Pstl was unable to digest LG and LGM1. The only way to positively prove that
the LGM2 and LGM1/2 constructs contained a Pstl recognition site was by
DNA sequencing. The results for one of these constructs, LGM2, is compared
with the DNA sequence of the wildtype plasmid in figure 3.2. It can clearly be
seen that while the SF-1-like sites 1 of these two constructs are identical,
there has been a mutation in the site 2 of the LGM2 construct. The same
sequencing comparison was also done between LGM1 and LGM1/2 (data not
shown) where once again their SF-1-like site 1 was identical (although it was
different from LG and LGM2), but their site 2 sequences were different due to
the mutation of LGM1/2. The sequencing evidence, together with the
restriction digestion results, positively proved that the mutagenesis of the SF-
1-like site 2 was successful.
2. The role of SF-1-like sites 1 and 2 of the GnRH receptor promoter in
basal transcription
The four constructs above (see figure 3.3) were further used in transfection
experiments, where they were transfected into aT3 cells together with the (3-
galactosidase expression vector, as a control for transfectional efficiency.
The cells were then lysed after an incubation period and luciferase and (3-
galactosidase (p-gal) assays were performed. The values from the luciferase
assay were divided by the corresponding (3-gal value to normalise the values
in terms of transfectional efficiency. For each experimental condition i.e.
construct type or incubation condition, duplicate experiments were performed.
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The luciferase and p-Gal assays were also done in duplicate for each
individual sample. Lastly experiments were repeated several times, to
establish significance of the data. To compare the normalised results i.e.
luciferase divided by p-Gal, from one experiment with those from another, the
average of the two wildtype LG values was calculated and all other values
were expressed as a percentage thereof (see table 3.1,3.2 and 3.3).
The four GnRH-R reporter constructs
SF-1 site 2
LG=
wildtype
LGM1
LGM2
LGM1/2
1
1
1
1
Figure 3.3: Diagrammatic view of the four different GnRH receptor promoter constructs. The
promoter region of the GnRH receptor was mutated and four different constructs were
created. These were then linked to a luciferase reporter plasmid. See methods (section 9) for
experimental detail. The SF-1-like site 1 is located at -14 to -5 relative to the ATG and SF-1-
like site 2 is situated at -247 to -238 relative to the ATG start codon. The sequences are as
follows: wildtype (wt) SF-1 site 1 = TGTCCTTGG, the mutated (mut) SF-1 site 1 =
TG I I I I ICC, the wt SF-1 site 2 = TGGCCTTCA and the mut SF-1 site 2 = GCAGCTTCA.
LUC represents the luciferase reporter gene. The black arrow shows the position of the
transcriptional start site at -63 relative to ATG. The figure is not to scale and was compiled by
G. Styger.
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In the first transfection experiment the relative contribution of the two putative
SF-1-like sites in the GnRH-R gene promoter to basal expression was
investigated. The basal promoter activity of the following four GnRH receptor
promoter constructs was tested in aT3 cells: LG (the wildtype construct),
LGM1 (site 1 mutated and site 2 unchanged), LGM2 (site 2 mutated and site
1 unchanged) and LGM1/2 (both sites mutated) (see figure 3.3). The results
from 3 independent experiments are shown in figure 3.4 (also see table 3.1).
Figure 3.4 shows that mutation of the SF-1-like site 1 (the proximal one)
causes a slight increase in transcriptional activity of the GnRH receptor
promoter, but this increase was not statistically significant. There was no
significant change in promoter activity, which indicates that site 1 does not
play a major role in basal expression of the GnRH receptor gene. The
mutation of the SF-1-like site 2 (the distal site) also had no significant effect
on GnRH receptor promoter transcriptional activity. However there was a
significant 50% or 2-fold decrease in reporter gene expression, compared to
wildtype, when both SF-1-like sites were mutated. This result was very
interesting in light of the evidence that mutation of site 1 alone or site 2 alone
had no effect on promoter activity. This evidence with the double mutant
indicates that SF-1 protein is indeed necessary for full basal expression, but
that only one SF-1-like element needs to be occupied i.e. SF-1 can either
bind to site 1 or site 2 to effect basal expression and it is only when it is
unable to bind to either site that basal expression is decreased. This
evidence further suggests that these sites are somehow positioned close to
one another when basal transcription takes place. The sites are
approximately 230 bases from each other and it is conceivable that they form
an association with each other due to chromatin structure or some other
unusual DNA structure.
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Figure 3.4: Effect of SF-1 site mutations on the basal transcriptional levels of four GnRH-R
reporter constructs. (X,T3 cells were transfected with one of four GnRH-R reporter constructs
together with a I3-Gal expression vector. Samples were transfected in duplicate and duplicate
assays were also done on each sample. The luciferase (Lucif) values were divided by the
corresponding I3-Gal (f3-Gal) value to get normalised expression for each of the samples. The
average of the wildtype (LG) was taken as 100% activity and all the other results from this
experiment were calculated as a percentage relative to it. Standard errors are shown and the
n value is 3. The * represents a P value smaller than 0.05 (P < 0.05) relative to LG.
3. Responsivenessof GnRH receptor promoter to protein kinase A
(PKA)activation
A.) The effect of PKA on the endogenous GnRH receptor gene
Transient promoter-reporter transfection experiments represent a very
artificial or in vitro situation, i.e. several copies of the promoter area of a
single gene are introduced into cells and this DNA is not integrated into the
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Table 3.1: Example of original data from a single representative experiment
on cells transfected with either one of four GnRH receptor constructs.
A B c D E F G H I
Luciferase j3-Galactosidase Lucif/J3-Gal 1% TO LG Ave STDEV
1 2 Mean 1 2 Mean I
LG a 0.074 0.084 0.079 0.038 0.051 0.044 1.789 103.9 5.520
b 0.069 0.119 0.094 0.063 0.050 0.057 1.655 96.11
LGM1 a 0.142 0.162 0.152 0.062 0.071 0.066 2.294 133.2 49.11
b 0.105 0.096 0.101 0.098 0.085 0.092 1.098 63.78
LGM2 a 0.080 0.077 0.079 0.038 0.084 0.061 1.296 75.29 0.742
b 0.050 0.057 0.054 0.039 0.045 0.042 1.278 74.24
LGM1/2a 0.035 0.027 0.031 0.092 0.096 0.094 0.330 19.16 19.42
b 0.065 0.117 0.091 0.057 0.170 0.113 0.803 46.62
Columns A and B show duplicate luciferase assay results (i.e. 1 and 2) for an individual experiment with a given construct and "a"
and "b" are the results from the duplicate cell incubation experiments for each construct. Column C contains the mean of columns A
and B. The same applies for columns D, E and F but the values are from ,a-Galactosidase assays. Column G shows the normalised
results, i.e.luciferase divided by .a-Gal to normalise for transfectional efficiency. The average of the duplicate control samples,
in this case LG, was then taken as 100% and all other results was calculated as a percentage of this value. This is contained
in column H. Lastly column I contains the standard deviation between the duplicate values for each construct.
~
Stellenbosch University http://scholar.sun.ac.za
75
genome. Therefore these transfected reporter constructs do not have the
natural chromatin structure that the endogenous gene would have. In an
attempt to use a more in vivo model, GnRH receptor mRNA levels in aT3
cells were measured after incubation with various compounds. The reason for
this was to see if the endogenous GnRH receptor gene is regulated by PKA
activation. This was done by incubating aT3 cells with forskolin, an activator
of adenylate cyclase which leads to an influx of extracellular Ca2+, or 8-
bromo-cyclic-adenosine monophosphate (8-Sr-cAMP), both PKA pathway
activators, and then isolating total RNA from these cells. The RNA was first
run on an analytical gel to make sure that the mRNAwas intact and that there
was no DNA contamination of the samples (see figure 3.5).
A B c D E F
Figure 3.5: Example of an analytical gel loaded with 1 ~g of total RNA isolated from aT3
cells incubated with or without various test compounds, showing the two ribosomal bands of
30S and 18S.
Figure 3.5 is an example of an analytical RNA gel and the amount of RNA
added for lanes A to F is 1 !lg total RNA per lane. However one would still
have expected to see bands of the same intensity between samples of the
same experiment, clearly this is not the case. This was due to the difficulty in
solubilising the RNA in solution. To overcome this problem subsequent total
RNA samples were read on the spectrophotometer at 260 nm just after the
isolation step. The samples were then stored at -80°C until they were used
for Northern blotting. On the day that the Northern blot was to take place the
RNA samples were thawed and incubated for 10 minutes at 55°C to ensure
complete solubilisation of the RNA before they were once again
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spectrophotometrically quantified and run on an analytical gel. After this
treatment the RNA once again proved to be intact, but the amount of RNA in
the different lanes was more equivalent. Unfortunately a picture of this gel
was not taken. Thus it is very important to include a (3-actinmRNA detection
step, because even if the loading amount was different between two samples,
the (3-actin mRNA normalisation will correct these differences. The RNA
samples were then run on a formaldehyde-containing agarose gel and
transferred onto a nitro-cellulose membrane before being probed with 32p_
labelled cDNA probes for GnRH receptor and (3-actin, a constituently
expressed housekeeping gene. The same membrane was first probed for
GnRH receptor, stripped and then reprobed with (3-actinprobe. An example of
a resulting autoradiograph can be seen in figure 3.6.
1 2 3 4 5 6 7 8
A
1 2 3 4 567 8
B
Figure 3.6: Autoradiograph of a single membrane, from one experiment, onto which RNA
was transferred and then UV crosslinked. The RNA was isolated from a.T3 cells incubated
with 1 mM 8-Br-cAMP (lanes 3 and 4), 10 J.lMforskolin (lanes 5 and 6), 100 J.lMforskolin
(lanes 7 and 8), for 18 hours, as well as cells that were not incubated with any test
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compounds and served as controls (lanes 1 and 2). After transfer, the membrane was
hybridised with a radioactively labelled 32p eDNA probe for GnRH receptor (panel A).
Thereafter the membrane was stripped and reprobed for using the ~-actin probe (panel B).
The GnRH receptor mRNA bands seen in panel A consist of a major band of 4.5 kb for lanes
1 - 8 and a very minor band of 1.8 kb for lanes 1 - 6. In lanes 7 & 8 the 1.8 kb band is
relatively more abundant. The ~-actin bands in panel Bare 2 kb in size.
It is clear from figure 3.6 that the intensity of the {3-actinband (panel B) is
similar through-out the experiment. This means that {3-actin expression is
unaffected by forskelm or cAMP and that it is an ideal control to normalise the
results for differences in the total amount of RNA between different samples.
Panel A shows the effect that increasing concentrations of torskelm or a
single concentration of 8-Br-cAMP have on the endogenous mRNA levels of
the GnRH receptor gene. When comparing lanes 3 and 4 i.e. the cells that
have been incubated with 1 mM 8-Br-cAMP, with the control lanes 1 and 2, it
is clear that there is a small increase in the intensity of the bands in lanes 3
and 4. This means that 8-Br-cAMP does indeed seem to increase GnRH
receptor mRNA levels. When one looks at the effects of forskolin on the
mRNA levels it also appears to increase the band intensities. Lanes 5 and 6
i.e. 10 11Mforskolin, are approximately 1.5 to 2 fold darker (judqed by eye)
than the control lanes. It is clear that the lanes with RNA isolated from cells
incubated with 100 11Mforskolin, i.e. lanes 7 and 8 are much more intense
than the control bands. It is also interesting to note that the minor band of 1.8
kb is much more intense than in any of the previous lanes. This might mean
that under certain circumstances e.g. activation of the promoter by the PKA
pathway, alternate transcription start sites are used, resulting in mRNA of a
smaller size. What the function of these alternate transcripts may be is still
unknown.
It is difficult to quantify fold differences by visual inspection of an
autoradiograph, as the quantification can be very subjective and different
observers might not agree that one particular band is for example 2-fold more
intense than another. In order to quantify these bands the autoradiographs
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were densiometrically scanned to determine the intensity of each band and
then given a numerical value. To correct for any variability in the amount of
RNA loaded, the GnRH receptor value was divided by the p-actin internal
control value. These results were then plotted on a histogram, with the
average of the two control values taken as 100%. All other values were then
expressed as a percentage relative to this value. The combined results from
densiometric scanning of Northern blots from five independent experiments
are shown in figure 3.7.
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Figure 3.7: Effect of 8-Sr-cAMP and forskolin on GnRH receptor mRNA levels in uT3 cells.
The cells were incubated with 1 mM 8-Sr-cAMP, 10 ).1Mforskolin (Forsk 10), 100 ).1M
forskolin (Forsk 100), for 18 hours, and some cells were not incubated with any test
compounds (Control). The resulting autoradiographs (see figure 5) were densiometrically
scanned and numerical values were given to each of the bands. In the case of the GnRH
receptor the densities of the 4.5 and 1.8 kb bands were calculated and added together. The
GnRH receptor values were divided by those for p-actin and the average of the two control
samples were taken as 100 % and all other values were plotted as a percentage thereof.
Standard errors are shown and the n value for the figure is 5. The * represent a P value of
less than 0.05 (P < 0.05) relative to control.
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The combined results of five independent experiments in figure 3.7 clearly
show that activation of the PKA pathway increases expression of the
endogenous GnRH receptor gene resulting in increased levels of mRNA. The
results with 10 JlMor 100 JlMforskolin and 1 mM 8-Br-cAMP are very similar
and they all caused an approximately 2.S-fold increase in the levels of GnRH
receptor mRNA. The question remained however as to the mechanism of this
effect: Was this increase the result of transcriptional control or did other
mechanisms such as post-transcriptional modification also playa role? This
was investigated in the next set of experiments.
B.) Does the PKA pathway effect the GnRH receptor gene at the
transcriptional level?
The next set of experiments were performed to see if any PKA responsive
elements are located in the 580 bp GnRH receptor promoter region, i. e.
spanning from -580 to -1 relative to the ATG, and whether the stimulatory
effect of the PKA pathway activation on the endogenous GnRH receptor gene
occurs at the transcriptional level. This was done by transfecting aT3 cells
with only the wildtype LG construct together with the l3-galconstruct, followed
by incubation for various time periods with 10 JlM forskolin, an adenylate
cyclase activator. The results of four independent experiments are shown in
figure 3.8. An example of original data from one such experiment is shown in
table 3.2.
After a six hour incubation with 10 JlM forskolin the promoter activity of the
wildtype GnRH receptor had increased by 3-fold over uninduced levels
(figure 3.8). The level of reporter gene expression after a twelve hour
incubation with 10 JlMforskolin showed a slightly higher increase than those
of the six hour incubation i.e. a significant 3.S-fold increase in promoter
activity over uninduced. It was very interesting to observe a time-dependent
response to forskolin, as the cells treated for 18 hours showed no difference
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in reporter activity compared to the control cells, while an even longer
exposure of 24 hours decreased GnRH receptor promoter activity by 2-fold.
The reason for this decrease is unknown, but some explanations could be
that forskolin becomes toxic to the cells after such a long period or that the
signalling pathways are desensitised and thus unable to respond to normal
cellular signals, leading to a decrease in cell viability and a general slowdown
of cellular processes. This would of course include transcription and
translation and might explain why reporter activity is lower than in control
cells.
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Figure 3.8: Incubation of wildtype GnRH-R reporter construct with 10 IlM forskolin for
varying times. uT3 cells were transfected with the wildtype (LG) GnRH-R reporter construct
together with a I3-Galexpression vector and incubated with 10 IlM forskolin for various time
periods (see table 2), before being harvested and assayed. Samples were transfected in
duplicate and duplicate assays were also done on each sample. The luciferase values were
divided by the corresponding I3-Gal value to get normalised expression for each of the
samples. The average of the wildtype (LG) was taken as 100% activity and all the other
results from this experiment were calculated as a percentage thereof. Standard error bars are
shown and the n value for the figure is 4. The • represent a P value of less than 0.05 (P <
0.05), while the" indicate a P value of less than 0.01 (P < 0.01) relative to control.
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Table 3.2: Example of original data from a single representative experiment
on cells transfected with the wildtype GnRH receptor construct
and incubated with 10 IJM forskolin for various time periods.
A B c D E F G H I
Luciferase ,a-Galactosidase Lucif/J3-Gal 1% TO LG Ave STDEV I
1 2 Mean 1 2 Mean I
Control a 0.020 0.050 0.035 0.104 0.117 0.111 0.317 67.39 46.07,
b 0.100 0.090 0.095 0.155 0.150 0.153 0.623 132.5
6 hr a 0.150 0.140 0.145 0.098 0.099 0.099 1.472 313.2 2.510
b 0.150 0.160 0.155 0.104 0.109 0.107 1.455 309.7
12 hr a 0.120 0.160 0.140 0.092 0.133 0.113 1.244 264.8 129.5
b 0.250 0.070 0.160 0.082 0.070 0.076 2.105 447.9
18 hr a 0.050 0.010 0.030 0.078 0.090 0.084 0.357 75.99 195.6
b 0.170 0.120 0.145 0.099 0.076 0.088 1.657 352.6
24 hr a 0.050 0.030 0.040 0.075 0.085 0.080 0.500 106.4 61.29
b 0.010 0.010 0.010 0.083 0.133 0.108 0.093 19.70
Columns A and B show duplicate luciferase assay results (i.e. 1 and 2) for an individual experiment with a given construct and "a"
and "b" are the results from the duplicate cell incubation experiments for each construct. Column C contains the mean of columns A
and B. The same applies for columns 0, E and F but the values are from j3-Galactosidase assays. Column G shows the normalised
results, i.e.luciferase divided by j3-Gal to normalise for transfectional efficiency. The average of the duplicate control samples,
in this case LG, was then taken as 100% and all other results was calculated as a percentage of this value. This is contained
in column H. Lastly column I contains the standard deviation between the duplicate values for each construct.
CX>.....
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Taken together the results clearly show that PKA activation by forskolin
stimulates transcriptional activity of the GnRH receptor promoter in a time-
dependent fashion. This result strongly suggests that at least part of the
increase in endogenous GnRH receptor mRNA shown in section 3A is in fact
due to an increase in transcription. However after 18 hours of incubation with
forskolin and/or 8-Sr-cAMP, a 2.5-fold increase in endogenous GnRH-R
mRNA levels was observed. At the same time point very little effect was seen
on the GnRH-R reporter construct, which suggests that some post-
transcriptional regulation may occur (see conclusions). The results also show
that there are indeed PKA responsive elements located in the 580 bp GnRH
receptor promoter fragment. The next experiment was set up to determine
whether this PKA effect was mediated via the SF-1-like site 1 (the proximal
site nearest to the ATG start codon).
4.) Role of SF-1-like site 1 in mediating the response to PKA activation
To determine whether site 1 contributed in any way to the stimulatory effect of
the PKA pathway on transcription of the GnRH receptor gene, aT3 cells were
transfected with either the wildtype (LG) or site 1 mutant (LGM1) constructs,
together with the p-Gal construct, followed by incubation in the presence or
absence of varying concentrations of forskolin for 12 hours. The results from
10 independent experiments can be seen in figure 3.9 and an example of
original data from one experiment can be seen in table 3.3.
As in figure 3.8, a 10 j.lM dose of forskolin for 12 hours increased GnRH
receptor promoter activity over uninduced or control (figure 3.9), but where
the stimulatory effect was 3.5-fold in figure 3.8, here as shown in figure 3.9
the fold increase was only about 1.5-fold. This lack of reproducibility caused
problems and forced the repetition of experiments to ensure that statistically
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significant differences were obtained, as some experiments showed no effect
with forskolin (see the section on optimisation for more information). The lack
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Figure 3.9: Effect of varying concentrations of forskolin on expression of two different GnRH-
R promoter reporter constructs. uT3 cells were transfected with either LG or LGM1 plasmid
and incubated with 0 (LG and LGM1), 1 (LG+1 F and LGM1+1 F), 10 (LG+10 F and
LGM1+10 F) or 100 (LG+100 F and LGM1+100 F) J..LMof forskolin for twelve hours before
harvesting. Cells were transfected in duplicate and duplicate assays were also performed.
The luciferase values were divided by the corresponding ~-Gal value to get normalised
expression for each of the samples. The average of the wildtype (LG), with no forskolin, was
taken as 100% activity and all the other results were calculated as a percentage thereof.
Standard errors are shown and the n value is 10. The ** represent a P value of less than 0.01
(P < 0.01), relative to the control (LG).
of reproducibility could have been due to the inherent variability in the
responsiveness of the cells between different experiments. Recent
information [119] highlights the effect that the number of passages have on
the characteristics of clonal cell lines. It would seem that the more times the
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Table 3.3: Example of original data from a single representative experiment on cells transfected with
the wildtype and site 1 mutant GnRH receptor constructs and incubated with
0, 1, 10 or 100 JJMforskolin for 12 hours.
A B c D E F G H I
Luciferase ,:I-Galactosidase Lucif/,:l-Gal 1% TO LG Ave STDEVj
1 2 Mean 1 2 Mean I
LG a 0.177 0.199 0.188 0.041 0.041 0.041 4.558 92.48 10.62
b 0.208 0.192 0.200 0.034 0.042 0.038 5.298 107.5
LG+1J.lM a 0.329 0.350 0.340 0.061 0.053 0.057 5.935 120.4 52.14
b 0.349 0.361 0.355 0.037 0.038 0.037 9.569 194.2
LG+10 j.JM a 0.275 0.315 0.295 0.040 .0.037 0.039 7.633 154.9 8.695
b 0.226 0.223 0.225 0.033 0.031 0.032 7.027 142.6
LG+100 J.lM a 0.155 0.146 0.151 0.025 0.027 0.026 5.879 119.3 13.04
b 0.141 0.108 0.125 0.027 0.024 0.025 4.970 100.9
LGM1 a 0.148 0.145 0.147 0.022 0.025 0.023 6.328 128.4 13.41
b 0.132 0.135 0.134 0.023 0.026 0.025 5.394 109.5
LGM1+1}JM a 0.355 0.338 0.347 0.100 0.108 0.104 3.338 67.74 24.42
b 0.342 0.354 0.348 0.071 0.068 0.069 5.040 102.3
LGM1+10 f.JM a 0.274 0.289 0.282 0.080 0.068 0.074 3.796 77.04 5.675
b 0.329 0.309 0.319 0.066 0.086 0.076 4.192 85.06
LGM1 +100 #JMa 0.114 0.111 0.113 0.033 0.030 0.032 3.571 72.47 13.29
b 0.117 0.115 0.116 0.050 0.038 0.044 2.645 53.68
- --_ ..._._ ... --_ ............... ~_ ............... ~._ ...._._ ..~
Columns A and B show duplicate luciferase assay results (i.e. 1 and 2) for an individual experiment with a given construct and "a"
and "b" are the results from the duplicate cell incubation experiments for each construct. Column C contains the mean of columns A
and B. The same applies for columns 0, E and F but the values are from I3-Galactosidase assays. Column G shows the normalised
results, i.e.luciferase divided by I3-Gal to normalise for transfectional efficiency. The average of the duplicate control samples,
in this case LG, was then taken as 100% and all other results was calculated as a percentage of this value. This is contained
in column H. Lastly column I contains the standard deviation of the duplicate values for each construct.
co.,..
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cells have been passaged, i.e. when confluent flasks are trypsinised to
remove the adherent cells and subsequently plated out less densely into new
flasks, the more undifferentiated they become. This partial revertment would
cause the cells to lose some of their gonadatrape characteristics, such as the
ability to respond to external or internal signalling pathways, like PKA, and
result in a scenario where the GnRH receptor promoter constructs in these
cells are no longer stimulated by PKA activators.
As shown in Figure 3.9 shows that 10 JlM forskelm resulted in 1.5 fold
increase reporter activity over uninduced. From figure 3.9 it can also be seen
that even a low concentration of 1 JlMforskolin appeared to increase reporter
activity by 1.2-fold, although this effect was not statistically significant.
However a forskelm concentration of 100 JlM had no effect on the GnRH
receptor promoter construct. The response to forskolin shows a similar trend
to the one shown in figure 3.8 and the reasons for this might be the same as
those discussed there. Indeed when one compares the f3-Gal values from
table 3.3, one can clearly see that the values are decreasing with an
increasing concentration of forskolin. This strongly suggests a cytotoxic or
desensitisation effect at high forskolin concentrations. The most interesting
result from figure 3.9, however, is the set of results where aT3 cells,
transfected with the mutated site 1 construct, LGM1, were incubated with
various concentrations of forskolin. The most obvious difference between
these set of results and those with the wildtype construct is the fact that the
increase in reporter activity caused by 10 JlM forskolin is not observed. The
GnRH receptor promoter activity of the site 1 mutant incubated with 1 or 10
JlM of forskolin is not significantly different to the uninduced control values.
These results would be consistent with a role for a SF-1-like protein being
responsible for mediating the stimulatory transcriptional effect of the PKA
pathway on the GnRH receptor gene promoter via binding to the SF-1-like
site 1 located 12 basepairs upstream of the ATG start codon.
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Table 3.4: Example of original data from a single representative experiment on cells transfected with
the wildtype and site 1 mutant GnRH receptor constructs and incubated with
0, 1, 10 or 100 )JM 25-hydroxycholesterol for 12 hours.
A B c D E F G H I
Luciferase a-Galactosidase Lucif/)3-Gal 1% TO LG Ave STDEV I
1 2 Mean 1 2 Mean I
LG a 0.233 0.218 0.226 0.061 0.066 0.063 3.557 130.2 42.70
b 0.101 0.100 0.101 0.045 0.060 0.053 1.907 69.80
LG+1f.JM a 0.395 0.418 0.407 0.071 0.073 0.072 5.634 206.2 21.32
b 0.213 0.218 0.216 0.049 0.041 0.045 4.810 176.1
LG+10 f.JM a 0.097 0.077 0.087 0.030 0.033 0.032 2.762 101.1 25.52
b 0.061 0.050 0.056 0.033 0.029 0.031 1.776 65.01
LG+100 f.JM a 0.008 0.010 0.009 0.032 0.025 0.028 0.317 11.62 4.053
b 0.012 0.009 0.011 0.022 0.022 0.022 0.474 17.35
LGM1 a 0.444 0.362 0.403 0.081 0.085 0.083 4.838 177.1 11.50
b 0.376 0.382 0.379 0.070 0.073 0.072 5.282 193.3
LGM1+1f.JM a 0.222 0.191 0.207 0.067 0.053 0.060 3.450 126.3 30.88
b 0.185 0.199 0.192 0.044 0.039 0.041 4.643 170.0
LGM1 +10 J.JM a 0.036 0.024 0.030 0.053 0.021 0.037 0.803 29.40 73.37
b 0.102 0.085 0.094 0.028 0.024 0.026 3.638 133.2
LGM1+100 f.JMa 0.014 0.024 0.019 0.011 0.018 0.014 1.315 48.13 14.27
b 0.007 0.013 0.010 0.012 0.014 0.013 0.763 27.94
- ---_ .....__ .... - ----
Columns A and B show duplicate luciferase assay results (i.e. 1 and 2) for an individual experiment with a given construct and "a"
and "b" are the results from the duplicate cell incubation experiments for each construct. Column C contains the mean of columns A
and B. The same applies for columns D, E and F but the values are from j3-Galactosidase assays. Column G shows the normalised
results, i.e.luciferase divided by j3-Gal to normalise for transfectional efficiency. The average of the duplicate control samples,
in this case LG, was then taken as 100% and all other results was calculated as a percentage of this value. This is contained
in column H. Lastly column I contains the standard deviation between the duplicate values for each construct.
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5. Responsiveness of the GnRH receptor promoter to 25-
hydroxycholesterol, the putative ligand for SF-1: Role of site 1
It has recently been proposed that 25-hydroxycholesterol (25-0HC) is a
ligand for SF-1. To test this hypothesis aT3 cells were transfected with the
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Figure 3.10: The effect of different concentrations of 25-hydroxycholesterol on two GnRH-R
promoter reporter constructs. aT3 cells transfected with either wild type or SF-1-like site 1
mutant constructs and p-galactosidase expression vector, were incubated with increasing
concentrations of 25-0HC l.e, 0 (LG and LGM1), 1 (LG+1 and LGM1+1), 10 (LG+10 and
LGM1+10) and 100 (LG+100 and LGM1+100) J..I.M,for 24 hours before being harvested.
Luciferase and p-Gal assays were performed and results expressed as luciferase over p-Gal.
The average of the wildtype (LG), with no 25-0HC, was taken as 100% activity and all the
other results were calculated as a percentage thereof. Standard errors are shown and the n
value is 10. The ** represent a P value of less than 0.01 (P < 0.01) relative to LG.
wildtype and the mutated SF-1-like site 1 GnRH receptor promoter
constructs, followed by incubation with varying concentrations of 25-0HC.
Figure 3.10 shows the combined results from 10 independent experiments
and the original results of one such experiment can be seen in table 3.4.
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From figure 3.10 it is clear that no effect on transcription was observed with 1
and 10 JlM25-0HC for the wildtype construct, but there was a significant 1.5-
fold drop in wildtype promoter activity when the cells were incubated with 100
JlM 25-0HC. When the SF-1-like site 1 mutant construct was investigated,
the same results were obtained as for the wildtype construct. It is interesting
to note that the inhibiting effect of 100 JlM25-0HC occurred in both wildtype
and site 1 mutant constructs, thereby suggesting that the binding of a SF-1-
like protein to site 1 is not necessary for the inhibitory effect of 25-0HC. One
possible explanation could be that 25-0HC becomes cytotoxic at these high
concentrations and that this is what causes the decline in transcriptional
activity seen at these concentrations. It is clear from table 3.4 that the
absolute f3-Gal values decrease with higher concentrations of 25-0HC,
possibly because the cells are in fact dying. It is also possible that the 25-
OHC response is mediated via SF-1-like protein, binding to site 2 rather than
site 1.
6. Optimisation of assays
It can be seen from the transfection results in the previous section that for
some series of data, the standard error for the results with different constructs
showed a high degree of variability (e.g. figure 3.8). Error bars for some
experiments were large, with a range of about 5 - 40% over the series of
data. When the statistical analysis was performed for the whole range of
experiments, those with large error bars decreased the ability to detect small
differences less than about 1-fold with statistical significance, i.e. it was
possible to detect differences of 1-3-fold but not smaller differences. One way
of dealing with the problem was to repeat some experiments up to ten times
(see figures 3.9 and 3.10). This was of course very time-consuming and used
up large amounts of expensive reagents. The ideal situation therefore would
have been to decrease experimental error to a minimum in order to be able to
detect statistically significant smaller differences with a maximum of six
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repeat experiments. The results in chapter 3, sections 1 -5, were, however,
generated without the benefit of the optimised conditions and it was hoped
that future researchers could benefit from these optimisation experiments.
There are many potential sources of variability during the performance of
these experiments. The first source is in the fact that there is an inherent
variability in the response. This means that some cells will react differently to
certain experimental conditions. This possible source of variability cannot be
eliminated and will always play a role in scientific experimentation. Other
sources of potential variability could include experimental error e.g.
differences in cell number, pipetting errors when adding DNA or test
compounds to the cells, and other manipulation mistakes. Other areas of
possible experimental error can be found in the assay protocols. The manual
method of doing the luciferase assays involved the pipetting of the cell
extracts into a plastic cuvette, as well as the pipetting of the luciferase assay
substrate and assay buffer. The cuvette had to be vortexed to mix the
different components and inserted into a luminometer where first a
background reading had to be taken. The actual result had to be manually
taken at a specific time after addition and the cuvette had to be carefully
washed out before the next sample was introduced. All these different steps
could introduce experimental error in the results.
When one looks at the actual data from various representative experiments,
i.e. tables 3.1,3.2, 3.3 and 3.4, it is easy to see where the biggest sources of
error lie. It is useful to estimate the percentage error that the following three
sources each contributed, i.e. the amount of error between experimental
duplicates "a" and "b", the error between luciferase duplicates and the error
between p-Gal duplicates. When the average percentage of experimental
error in the four tables was estimated, it was clear that the experimental
duplicates were the major source of error i.e. 40 - 60%. The estimated
percentage error between p-Gal duplicates was around 10 - 30% and that of
luciferase duplicates around 7 - 20%.
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The main contributing factors to the large variability in experimental
duplicates could either be error in plating out the cells or the inherent
variability of the cells. Steps were taken as far as possible to ensure the most
accurate pipetting. Cells were plated as carefully as possible by sucking up
and down to avoid variability in the concentration of cell suspensions. Protein
determination assays were performed on cell extracts (not shown) to
determine if the plating of the cells was accurate. These protein
determinations showed that the plating of the cells was indeed accurate, so
that when results were expressed as luciferase over ~-Gal over protein
concentration, the error in the duplicates did not improve. It was thus
concluded that most of the variability in the duplicates was due to inherent
experimental variability.
It was thus decided to focus more attention on the luciferase and ~-Gal
assays. The laboratory recently acquired an automatic luminoskan machine
that eliminated most of the manual pipetting steps during luciferase and ~-Gal
assays. The only pipetting step remaining was the pipetting of the cell
extracts into a 96-well plate. The luminoskan would then automatically add
the luciferase assay substrate, mix the contents of the wells in the plate, read
the results after a defined time period and give a printout of the results. An
added advantage was that the reaction could be scaled down by half, thus
ensuring that the luciferase kit could be used for double the number of
reactions as previously.
In figure 3.11 the result from a pilot study on reproducibility between the
manual and luminoskan method can be seen. The same sample was read six
consecutive times in the manual luminometer and it was also pipetted into six
wells of a 96-well plate and automatically read. The average of the six
samples was taken as 100% in each case and all other values were
calculated as a percentage thereof. It is clear that the manual method of
assaying resulted in a large error bar, i.e. the six readings differed by a
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estimated 30% standard deviation, whilst the luminoskan method resulted in
a dramatically decreased error bar with a standard deviation of about 2%.
o
Luminometer
c::J Lumnorreter
mmManual
Manual
Assay type
Figure 3.11: The difference in reproducibility between manual and luminoskan assay
methods. Six consecutive readings of the same sample were performed in both the
luminometer and with the manual method. The average of the results was then taken as 100
% and all values were expressed as a percentage thereof. Standard errors are shown and the
n value is six.
The added advantage of the luminoskan was that both luciferase and p-
galactosidase assays could be performed using chemiluminescence.
Previously the p-Gal assays were done by a manual spectrophotometric
method that also involved numerous pipetting steps and a colour reaction
(see materials and methods). The p-Gal kit (Galacto-Star™,Tropix) used in
the optimisation procedure is almost identical in methodology to the
luciferase assay, but requires an additional incubation step and also utilises
the automatic pipetting of the luminoskan machine. The assay makes use of a
light-emission accelerator containing a polymeric enhancer [120].
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Figure 3.12: Comparison of linearity and sensitivity between the chemiluminescent Galacto-
Star assay (Panel A) and the manual spectrophotometric assay (Panel B). Various volumes
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(J.lI)of cell extracts from aT3 cells used in previous experiments were assayed in duplicate
with the two different methods and standard curves drawn.
A comparison between the linearity and sensitivity of the manual
spectrophotometric assay and the chemiluminescent Galacto-Star™ assay
can be seen in figure 3.12.
It is apparent from figure 3.12 that the Galacto-Star assay is linear from 0.5 to
2.5 relative light units (RLU) and throughout the range of cell extract volumes
from 3 - 10 Ill, whilst the manual assay is only linear between 0.005 - 0.06
00420 and between 0.2 - 2 III of cell extract before the line approaches a
plateau. This seems to indicate that the manual method is more sensitive i.e.
that it can be used to measure differences more accurately between smaller
amounts of extract and that it is linear from 0.2 to 2 Ill, whereas the Galacto-
Star assay is less sensitive i.e. it cannot be used to measure the difference
between 1 and 2 III cell extract, but that it is linear over a wider range, 3 - 10
Ill. This linearity means that if 3 III of cell extract gave a reading of X RLU,
then 6 III would give a reading of 2X RLU. The reason for the short range of
linearity found in the manual method might be due to the fact that the
substrate might be limiting. Whatever the case may be, this result was
somewhat disconcerting as some of the p-Gal assay values for the previous
transfection experiments were performed with the manual method using 20 III
of cell extracts and obtaining 00420 readings much higher than 0.08. Most of
the assays however had p-Gal values of less than 0.08. Even if some of the
p-Gal values were inaccurate, it would not have effected the overall results,
due to the large number of experiments that were done.
Since a major advantage of the luminoskan method over the manual assay
method would hinge around the fact that the machine automatically pipetted
assay substrate into wells of a 96-well plate, the reproducibility of the
machine in this regard was tested. This was done by designating different
areas on a 96-well plate and pipeUing the same amount of cell extract into
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each well in this block (see table 3.5) and then conducting a luciferase assay.
The results are shown in figure 3.13.
Table 3.5: Designated blocks on a 96-well plate to test for automatic pipetting consistency
1 2 3 4 5 6 7 8 9 10 11 12
A A
B D F
C
0
E
F .1
G B
~~~
E
H ,
As can be seen from figure 3.13, there are no statistically significant
differences between the samples from the different areas on a 96-well plate.
Note that this experiment Clot only assessed the automatic pipetting by the
machine, but also the reproducibility of all parts of the assay, i.e. pipetting
and detection in different areas of the 96-well plate. It can thus be concluded
that the pipetting of assay substrate into different areas on the plate as well
as the detection from different parts on the plate was highly reproducible.
In conclusion these results show that although the Galacto-Star I3-Gal
luminoskan assay method was not as sensitive as the manual I3-Gal method
in detecting differences between small amounts of cell extract, it had a much
wider linear range of detection. The luminoskan method for both the Galacto-
Star and luciferase method resulted in decreased experimental error, most
likely by decreasing the amount of pipetting and handling steps. The wide
linear range of the Galacto-Star assay would make it possible for future
researchers to optimise their experimental conditions with the minimum
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amount of experimental manipulation. Lastly it was shown that the
luminoskan could automatically dispense and detect reproducibly in all areas
of a 96-well plate. Thus future experiments could definitely benefit from the
use of chemiluminescent luciferase and f3-Gal assays performed in an
automatically dispensing luminometer.
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Figure 3.13: Comparison of different areas on a 96-well plate, with regard to the
reproducibility of automatic pipetting and detection of the luminoskan machine. Cell extract
was pipetted into various areas in a 96-well plate (see table 3.5) and the luminoskan then
automatically dispensed luciferase assay substrate into target wells. The values of each area
was used to generate a histogram with standard errors. The n values for each area differs i.e.
the n value for area A, Band D is 6, C is 3, E is 4 and F is 9. The P value for this experiment
was 0.1595.
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CHAPTER4
CONCLUSIONS
The promoter of the mouse GnRH receptor gene contains two potential SF-1
DNA-binding sites, i.e. at -247 and -14, relative to the ATG start codon. In this
study, the role of steroidogenic factor-1 (SF-1) in the transcriptional
regulation of the mouse gonadotropin-releasing hormone receptor (mGnRH-
R) gene was investigated. SF-1 is an important regulator of steroidogenic
gene expression and it is thought to act throughout the hypothalamic-
pituitary/gonadal (HPG) and hypothalamic/pituitary/adrenal (HPA) axes. In
general, various levels of transcriptional control exist, e.g. basal, cell- and
tissue-specific regulation. In addition, controls are also exerted by hormonal
and other signalling molecules which transiently modulate levels of gene
expression via various intracellular signalling pathways like PKA or PKC. The
mechanism of action and the role that SF-1 protein plays in all these levels of
regulation is of great importance in elucidating the final picture of
transcriptional control of the GnRH receptor gene.
SF-1 protein was initially thought to be the factor regulating the cell-specific
expression of the gonadotrope genes, and SF-1 was identified as the protein
that bound to the GSE in the a-subunit gene in vitro [6, 7]. It became
apparent, however, that SF-1 protein was not the single determining factor
that conferred cell-specific expression to these genes. It was later found that
SF-1 protein, in conjunction with other tissue-specific DNA-binding factors, is
involved in cell-specific basal expression of the GnRH receptor gene [62, 67].
Studies done on regulation of the various steroidogenic hormone genes, by
SF-1 protein, also identified a different role for SF-1 protein, i.e. not only was
SF-1 protein important in tissue-specific or basal expression of these genes,
but in some cases it was found to mediate the effect of the PKA second
messenger pathway on these genes [87, 90, 93, 95, 97 - 99]. This suggested
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a pivotal role for SF-1 in gene regulation in the HPAlHPG axis and opened up
the possibility that SF-1 might also fulfil this role on the GnRH receptor gene.
This is, however, a controversial issue. There is no consensus in the
literature about whether or not the GnRH-R gene is stimulated by activation
of the PKA pathway. In addition, while results imply that SF-1-like site 1 and 2
are not involved in mediating a response to PKA [69], the role of sites 1 and 2
have not been directly investigated.
Another mystery still surrounding SF-1 protein is that of a possible ligand. A
possible candidate is the oxysterol 25-hydroxycholesterol (25-0HC). This
oxysterol was touted as the new ligand for SF-1 [111], but these experiments
were performed in non-steroidogenic cells. However, other researches found
that in a steroidogenic cell line, 25-0HC did not act as a ligand for SF-1
protein [113]. This issue is as yet still unresolved and has important
implications for gene regulation in the HPAlHPG axis. If the ligand for SF-1
protein can be identified it would elucidate one more level of control over an
already immensely complex system.
As stated above, the mGnRH-R gene promoter contains two SF-1-like sites.
At the start of this study little information existed on the actual role of site 1.
No known function was proposed for this site. It was shown to have no effect
on basal or tissue-specific expression of the mGnRH-R gene [59]. SF-1 was
proposed to bind to this site, but no binding data were reported in the
literature. This site was also not directly tested for a role in a PKA response,
but the general consensus was that it was not involved and played no
important part in regulation of the mGnRH-R gene. On the other hand, site 2
was well studied and found to be necessary for gonadotrope specific
expression of the mGnRH-R gene [59, 62, 67]. It was functionally shown, with
antibody shifts, that this site could bind SF-1 protein in vitro [62]. However,
this site was also not tested directly for a role in a PKA response.
It can thus be seen that, at the start of this MSc study, there were still a
number of important questions to be answered regarding SF-1 protein and
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the transcriptional regulation of the GnRH receptor gene. Firstly there was
the question of whether SF-1 protein plays any role in basal expression of the
GnRH-R gene. Secondly, another important question was whether the
endogenous GnRH-R gene is regulated via the PKA pathway and whether
SF-1 mediates this response. From the introduction section it is clear that the
main regulator of this gene is its own ligand, GnRH. If the GnRH-R gene is in
fact sensitive to the actions of the PKA pathway this could suggest that
regulation of this gene by GnRH can occur through the PKA pathway, since
there is evidence that GnRH activates the PKA pathway in animals [1, 22]. It
is however also possible that other factors such as sex steroids or other
signalling molecules that activate the PKA pathway can regulate expression
of the GnRH-R gene. Another outstanding question was whether 25-0HC
acts as a ligand for SF-1 in the non-steroidogenic a.T3 cells.
Work previously done on mouse GnRH-R gene regulation in our laboratory
identified the major transcriptional start site in a.T3 cells and in mouse
pituitary tissue at position -63 relative to the transcriptional start site
(Hapgood, J.P. ef aI., unpublished) and showed that the SF-1-like site 1
played no part in conferrinq tissue-specificity to the mGnRH-R gene [58]. It
was also shown that a protein from a.T3 cells could bind to this site. These
findings were consistent with work done by other researchers [59]. The work
in this thesis is a continuation of this study and focuses on other aspects of
GnRH-R gene regulation.
The a.T3 clonal mouse pituitary gonadatrope cell line was used as a model
system in this study. The -580 to -1 bp promoter region, containing the two
SF-1-like sites, of the mouse GnRH receptor (mGnRH-R) gene was
investigated. Mutagenesis of these sites and subsequent transfection of
reporter plasmid constructs into a.T3 cells formed the basis of most of the
experiments performed during this study. Levels of endogenous mGnRH-R
mRNA were also studied and compared to results obtained with transfection
experiments. Another important part of this study was to investigate the role
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of the protein kinase A pathway in the regulation of the mGnRH-R gene and
the role that SF-1 played in this regulation. The last area of investigation was
the role of 25-hydroxycholesterol (25-0HC) in SF-1-dependent transcription
of the mGnRH-R in aT3 cells.
Results obtained during this study showed that mutation of either SF-1-like
site 1 alone or site 2 alone, had no effect on basal transcription of the
mGnRH-R gene in aT3 cells. However simultaneous mutation of sites 1 and 2
led to a 50% reduction in transcriptional activity. The results with the
individual mutations indicate that efficient basal expression of the GnRH-R
gene requires the presence of at least one intact SF-1 site, occupied by SF-1
protein. The results imply that the occupation of both sites simultaneously by
SF-1 is not necessary for basal expression. It is also conceivable that other
nuclear receptors can bind to these mutated SF-1-like DNA-binding site and
fulfil the role of SF-1 protein. Indeed this is the subject of a parallel study, by
Hanel Sadie, done in this laboratory using electrophoretic mobility gelshift
assays to investigate the proteins able to bind to the wildtype and mutated
SF-1-like sites. Lastly it is thought that the two SF-1-like sites could somehow
be positioned close together. This would facilitate the mechanism whereby
anyone of the two sites is important for basal expression of the mGnRH-R
gene. Whether this coming together of the two sites takes place under
physiological conditions is not yet known, but DNA looping and alterations in
chromatin structure could be involved.
Previous work done in aT3 cells, [67] identified a tripartite enhancer in the
mGnRH-R gene, consisting of a AP-1, SF-1 (i.e. site 2) and GRAS elements.
These elements cooperate to regulate basal expression of the mGnRH-R
gene and mutation of one single element alone led to a 60% decrease in
transcriptional activity, whilst mutation of any two elements gave a 80%
reduction in basal expression. Mutation of all three elements completely
abrogated basal expression. The results obtained from the present study
showing no effect when SF-1-like site 2 alone was mutated appear initially to
Stellenbosch University http://scholar.sun.ac.za
100
be inconsistent with the above mentioned findings. One possible reason for
this could be that the construct used by Duval, D.L. et al. [67] and the
construct used in the present study differ slightly in the 3' sequence of the
SF-1-like site 1. The sequence of the SF-1-like site 1 in the construct used in
this study was: TGTCCTIGGAGAAAGATCT and contained the 3'-immediate
wildtype flanking sequence, whereas the Duval, D.L. et al. sequence was:
TGTCCTIGGAGAAAtatgg. The differences in their construct compared to
the one in the present study are indicated in lower case letters and the
sequence shown to playa role in SF-1-DNA interaction is underlined. It is,
however, not known whether these differences have any functional
significance and apparent differences between results could have been due
to other factors, like differences in culture conditions and assay types. It is
interesting to note that simultaneous mutation of two SF-1 sites in the murine
cytochrome P450 side-chain cleavage enzyme gene, led to a dramatic 7-fold
decrease in basal transcription of this gene [90]. Unfortunately single
mutations were not performed in this study and it is thus unknown whether
basal transcription of this gene would also require the presence of only one
intact SF-1 site as is the case in the mGnRH-R gene.
The results of the present study showed that activation of the PKA pathway
led to an increase of endogenous mGnRH-R mRNA levels. Only one other
study has reported an investigation into the effect of activation of the PKA
pathway on endogenous GnRH-R mRNA levels. This was done by Alarid,
E.T. and Mellon, P.L. (1995) [49], who found that forskolin caused a decrease
in GnRH-R mRNA levels in aT3 cells. It is difficult to reconcile these results
with the increases seen in the present study or the increases reported in the
literature. The cell types used were the same, but the decreases were
observed for time points of less than 12 hours. After 24 hours of incubation
the mRNA levels were almost the same as for unstimulated cells. In the
present study only the 18 hour time point was investigated by Northern
blotting. It is possible that forskolin results in a decrease in the endogenous
GnRH-R mRNA levels for the first few hours of incubation, after which the
Stellenbosch University http://scholar.sun.ac.za
101
levels start to rise, although it is unknown what the physiological reason for
this could be. The mechanism for the increase seen in this study, however,
was still unclear: Was this a case of transcriptional or post-transcriptional
regulation? Transfection experiments are an ideal way of testing whether a
certain response is in fact transcriptional or not, because it is possible to
measure the activity of a certain gene promoter directly. Results from
transfection experiments corroborated the mRNA results and showed that the
PKA pathway could directly influence the promoter of the mGnRH-R in the
aT3 cell line. In promoter transfection studies (fig. 3.8), it interesting to note
that at 12 hours incubation time, with 10 JlMforskolin, the GnRH-R promoter
reached a maximumfold induction of 3.5 and that the fold induction for the 18
hour incubation was only 1.1-fold. The Northern blot mRNA studies on the
other hand show that after 18 hours incubation time, with 10 JlMforskolin, the
maximum fold induction was 2.7-fold (fig. 3.7). This is extremely interesting
and could mean that the effect of the PKA pathway is firstly only a
transcriptional effect, up to 12 hours incubation time. At the 18 hr incubation
time, the transcriptional effects may have ceased, but there may still have
been a strong post-transcriptional effect in place. Perhaps a more likely
explanation could be that the stability of the endogenous GnRH-R mRNA is
greater than that of the luciferase reporter mRNA. This could have caused
the luciferase reporter mRNA to be degraded by 18 hours, whilst there may
still have been a high level of endogenous GnRH-R mRNA present at 18
hours. It is unknown whether such an effect could also take place in vivo.
The next obvious question was whether SF-1 plays any role in this PKA-
dependent regulation, i.e. is this effect mediated via the SF-1-like DNA-
binding sites in the mGnRH-R gene promoter? The present study showed
that when the SF-1-like site 1 was mutated, the PKA-dependent increase in
transcription was lost. Only site 1 was studied, however, due to time
constraints. It would have been interesting to have had the results for both
site 1 and site 2 in order to have the complete picture. Recent work done in
GGH3 cells by Maya-Nunez and Conn [69], identified a CRE element at
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position -100 (relative to the ATG) in the mouse GnRH-R gene that is
responsive to the PKA pathway and showed that mutation of this element
abrogates the effect of PKA [69]. These results imply that sites 1 and 2 are
not involved in mediating the PKA response, as they lost the effect if the CRE
was mutated. These results at first appear to contradict the results of the
present study. The direct involvement of sites 1 and 2 was, however, not
tested by mutation or deletion of these sites. It can also be argued that GGH3
cells are not pituitary gonadotrophs and therefore might not have the same
transcriptional mechanisms as aT3 cells and might not even express SF-1
protein. If that is indeed the case, then the putative CRE might be inactive in
aT3 cells, where the PKA-dependent response is mediated by SF-1-like site
1. Another possibility could also be that both the SF-1-like site 1 and the
putative CRE work together to mediate the PKA response in aT3 cells.
Evidence for such a co-operation was found in the rat aromatase gene
promoter [85, 86]. This promoter also has a CRE about 80 basepairs
upstream of the SF-1 site and it was found that both these elements were
required for transcriptional activation of this gene by PKA. Interestingly, the
fold increases found by Maya-Nunez and Conn [69] with forskelm treatment
were in the 10% range. Such small increases would probably not have been
detected with the assay systems used in this study. Thus in the present
study, the response to PKA activation by an intact CRE and a mutated SF-1-
like site 1 would not have been detected as statistically significant, even
though there might have been a small 10% increase in promoter activity
above uninduced control.
However, other work done in aT3 cells [60] showed that the PKA pathway is
not involved in transcriptional regulation of the mGnRH-R gene, but that the
PKC pathway fulfils this function. The authors further identified the AP-1
element, situated at -337 relative to the ATG, as important in mediating this
response. Whilst these results may seem contradictory to results obtained in
this study, it is important to remember once again that factors such as
construct type (they also used the construct with the different 3'-flanking
Stellenbosch University http://scholar.sun.ac.za
103
sequences to the SF-1-like site 1, see above), the use of different culture
conditions, i.e. different media, the use of antibiotics, the presence or
absence of serum, as well as different number of passages for the aT3 cells,
could result in variability in responses to cAMP and forskolin in aT3 cells in
different laboratories. The finding presented in this thesis that the SF-1-like
site 1 mediates the PKA response of the GnRH-R gene in aT3 cells is
consistent with the role for SF-1 found in several other genes in other tissues,
i.e. rat [85, 86] and human [87, 88] aromatase, rat [89, 90] and bovine [92]
cholesterol side-chain cleavage, rat [93] and bovine [94] 17a-hydroxylase,
human [95, 98], rat [96] and mouse [97] steroidogenic acute regulatory
protein as well as the rat high density lipoprotein receptor [99].
The penultimate series of results generated during this study involved 25-
hydroxycholesterol (25-0HC) and more precisely whether 25-0HC could
effect SF-1-dependent transcription of the mGnRH-R in aT3 cells. No effect
was found with 25-0HC at lower concentrations (1 JlM and 10 JlM) for either
of the wildtype or site 1 mutant constructs. One interpretation of the results
would be that since 25-0HC was not able to enhance SF-1-dependent
transcription of the mGnRH-R gene in aT3 cells, then it is unlikely to be a
ligand for SF-1 protein. It is, however, also possible that this decrease is a
transcriptional effect and that it is mediated by a factor binding at a site other
than site 1. Another possible explanation would be that the ligand, 25-0HC,
was already present in these cells and addition of further 25-0HC had no
effect on an already saturated system. Further experiments would be required
in future to unravel these intriguing possibilities. However, at high
concentrations of 25-0HC (100 JlM) there was a 50% decrease in
transcriptional activity for both the constructs. It is suggested that at these
high concentrations, 25-0HC become cytotoxic and started to kill the cells.
Visual inspection did not detect changes in the numbers and appearances of
the cells at these high 25-0HC concentrations. Table 3.4 however clearly
showed that the luciferase and p-Gal values of both the wildtype and site 1
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mutant construct decreased with an increased 25-0HC concentration,
consistent with a cytotoxic effect.
The last area that was investigated was the optimisation of the luciferase and
J3-Galactosidaseassays. It was found that future researchers ean benefit from
using an automatic luminometer with automatic pipetting, together with
chemiluminescent detection kits for both luciferase and J3-Galactosidase.The
luminoskan, with automatic pipetting, was able to decrease experimental
error, normally in the 30% range for the manualluciferase assay, to about 2%
for the same assay done in the luminoskan. An added benefit was the sealing
down of the luciferase assay. Half the previous volume of reagent was
needed, resulting in a doubling of the number of assays that could be
performed with the luciferase detection kit. The chemiluminescent Galaete-
Star J3-Gal assays compared very we" with the manual J3-Gal assay, with a
superior linear range from 3 - 10 JlI, compared to the 0.2 - 2 JlIof the manual
method. However the manual method was more sensitive to differences
between small volumes of celt extract. The wide linear range of the Galacto-
Star assay could be very useful in optimising future experimental procedures
with the minimum number of manipulations. The fact that the manual method
was proven to be linear to only 0.06 00 units was worrying as some of the
results generated via this method had values of more than 0.08 00 units. The
linearity study for the manual J3-Gal was only done later, together with the
optimisation studies that were done on the automatic luminometer. With the
benefit of hindsight it is clear that the linearity of the manual J3-Gal method
should have been performed at the start of the study and that it would have
been wise to have repeated J3-Gal assays on some of the samples with
values larger than 0.08 00420, after dilution.
In summary, this study showed that the presence of one intact SF-1-like site
in the promoter region of the mGnRH-R gene is necessary for basal
expression of this gene, and that the absence of both SF-1-like sites leads to
a 50% decrease in promoter activity. It was also shown that the PKA pathway
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was able to increase mRNA levels of endogenous mGnRH-R gene in aT3
cells, and that this increase was most likely largely due to a transcriptional
effect, but that evidence consistent with some post-transcriptional effects was
also found. It was also shown that the SF-1-like site 1 mediated this PKA-
dependent response. Lastly it was shown that in aT3 cells, the oxysterol 25-
hydroxycholesterol, could not be shown to be a ligand for SF-1 protein.
Optimisation experiments done during this study showed the advantages of
using chemiluminescent detection kits in conjunction with an automatic
dispensing luminometer.
One of the main implications of the findings in this study is to add to the
increasing body of evidence that SF-1 protein plays a major role in the HPG
axis. In this study, SF-1 protein was shown to regulate basal transcription of
the GnRH receptor gene via either site 1 or site 2. It is interesting to note that
a SF-1 site is conserved in the 5'-untranslated regions (5'-UTR) of the mouse
(site 1), rat and human GnRH-R genes. This positional conservation is
consistent with an important role for this SF-1 site in the transcriptional
regulation of the GnRH-R gene. Since SF-1 is an orphan member of the
nuclear receptor superfamily it is very important to identify its ligand, if indeed
there is a ligand, in order to fully understand the signals that control the
genes regulated by SF-1. In this study it was shown that it is unlikely that 25-
OHC is indeed the ligand of SF-1 in aT3 cells. What was however clear from
this study is that the PKA pathway can stimulate gene expression of the
GnRH receptor gene in aT3 cells and that this effect is mediated via SF-1-like
site 1. The important question of the mechanism by which SF-1 responds to
PKA remains to be answered. Evidence for mechanisms involving indirect
effects of PKA on SF-1 protein, obtained by others for some genes expressed
in adrenal cell lines, include an increase in SF-1 mRNA levels, after treatment
with forskolin [104], as well as post-translational modification of SF-1 protein
[87]. Direct effects of PKA on SF-1 protein, shown by others for some genes
expressed in adrenal cell lines, include direct phosphorylation of serine and
threonine residues [93] or interactions via the activation function-2 (AF-2)
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domain [94]. It is unknown which of these mechanisms take place in uT3
cells. The fact that the main regulator of this gene is its ligand, GnRH, raises
the possibility that GnRH makes use of the PKA pathway and SF-1 protein to
regulate transcription of its receptor gene. The potential also exists that the
GnRH receptor gene can respond to multiple signals from the HPAlHPG axes
e.g. ACTH, LH or FSH, or other factors that act via GPCRs or couple to Gs or
Gi proteins. Whether receptors for these hormones occur in pituitary
gonadotropes remains to be determined.
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APPENDIX A
Solutions
LB medium (Luria-Bertani Medium)
Per litre of deionized water add:
bacto-tryptone 10 9
bacto-yeast extract 5 9
NaGI 10 9
Sterilise by autoclaving
soc medium
Per litre of deionized water add:
bacto-tryptone 20 9
bacto-yeast tryptone 5 9
NaGI 0.5 9
Add 10 ml of a 250 mM solution of KGI. Adjust the pH to 7.0 with 5 M
NaOH. Adjust the volume to 1 litre and sterilise by autoclaving. Just
before use add 5 ml of a sterile solution of 2 M MgGb, and 20 ml of a
sterile 1 M solution of glucose.
SOB Medium
SOB medium contains the same nutrients and salts as SOG (above),
but lack the glucose.
20 X sse Solution
Dissolve 175.3 9 NaGI and 88.2 9 of sodium citrate in 800 ml water.
Adjust the pH to 7.0 with addition of a few drops of 10 M NaOH. Adjust
the volume to 1 litre and dispense into aliquots. Sterilise by
autoclaving.
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EDTA 1 9
NaCI 40 9
KCI 1 9
NaH2P04 5.75 9
KH2P04 1 9
Glucose 1 9
Trypsin (SOH) 6.25 9
TE buffer pHS
10 mMTris.HCI (pH 8)
1mMEDTA (disodium salt) (pH 8)
10 X Trypsin Solution
Per 500 ml deionized water:
Adjust the pH to 7.2-7.4. Make up the volume to 500 ml with water.
Filter sterilise and store at -20°C.
10 X MOPS Buffer
Morpholinopropanolsulfonic acid
Sodium Acetate
EDTA (disodium salt)
DEPC-treated H20
41.86 9
4.10 9
3.72 9
to one litre
Adjust the pH to 6.0
2 X HeBS (HEPES Buffered Saline)
Dissolve 1.6 9 of NaCl, 0.074 9 of KCI, 0.027 9 of Na2HP04, 0.2 9 of
dextrose and 1 9 of HEPES in 90 ml of deionized water. Adjust the pH
to 7.05 and make the volume up to 100 ml. Sterilise through 0.22
micron filter and store in aliquots at -20°C.
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\APPENDIX B
Plasmid constructs
500 bp
GnRH-R
5'-Flank
Structure of the GnRH-R promoter
reporter construct
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